Skip to main content
PLOS One logoLink to PLOS One
. 2024 Apr 18;19(4):e0301994. doi: 10.1371/journal.pone.0301994

Impact of COVID-19 on antenatal care provision at public hospitals in the Sidama region, Ethiopia: A mixed methods study

Zemenu Yohannes Kassa 1,2,*, Vanessa Scarf 1, Sabera Turkmani 1, Deborah Fox 1
Editor: Fekede Asefa Kumsa3
PMCID: PMC11025829  PMID: 38635578

Abstract

Background

Coronavirus disease 2019 (COVID-19) continues to pose a global public health threat. The pandemic overstretched already weak health systems in low- and low-middle-income countries, including Ethiopia. There is a paucity of studies on the impact of COVID-19 on antenatal care access, uptake, and provision in Ethiopia. This study examines the impact of COVID-19 on antenatal care provision in the Sidama region, Ethiopia.

Methods

A concurrent mixed-methods study was conducted between 14 February and 10 May 2022 at 15 public hospitals in the Sidama region. An interrupted times series design was applied for a quantitative study, which included data from all pregnant women who attended antenatal care before COVID-19 (12 months, March 2019 to February 2020) and during COVID-19 (six months, March to August 2020) at 15 public hospitals in the region. The total numbers in the antenatal care 1 cohort (at least one antenatal care contact) and antenatal care 4 cohort (at least four antenatal care contacts) were 15,150 and 5,850, respectively, forming a combined final dataset of 21,000 women. Routinely collected monthly data were derived from the hospitals’ health management information system and imported into Stata version 17 for analysis. The mean monthly incidence rate ratio of antenatal care uptake was calculated using a Poisson regression model with a 95% confidence interval. Simultaneously, an exploratory study design was conducted for qualitative using in-depth interviews to explore maternity care providers’ perceptions of the impact of COVID-19 on antenatal care access, uptake, and provision. Qualitative data were thematically analysed. The quantitative and qualitative findings were then integrated using the joint display technique.

Results

Our findings indicate a significant monthly decrease of 0.7% in antenatal care 1 and 1.8% in antenatal care 4 during the first six months of the pandemic. A lack of medical supplies, fear of contracting COVID-19, inadequate personal protective equipment, discrimination against those attending the hospital, and the absence of antenatal care guidelines for care provision, COVID-19 vaccine hesitancy and long waiting times for ANC led to disrupted access, uptake, and provision of antenatal care during COVID-19.

Conclusion and recommendations

Our findings demonstrate that the COVID-19 pandemic affected antenatal care access, uptake, and provision in the study area from March to August 2020. To mitigate disrupted antenatal care access, uptake and provision, antenatal care clinics should be equipped with medical supplies. It is crucial to maintain rapport between the community and maternity care providers and provide training for maternity care providers regarding the adapted/adopted guidelines during COVID-19 at the hospital grassroots level for use in the current and future pandemics. Pregnant women should have timely access to maternity care providers in order to maintain at least a minimum standard of care in current and future pandemics.

Introduction

The coronavirus disease 19 (COVID-19) has created an unprecedented global public health crisis and continues to pose a global health threat [1]. It is a highly contagious viral pneumonia that causes severe acute respiratory syndrome (SARS-CoV-2) [2]. COVID-19 is a rapidly spreading virus with cases throughout the world since its first identification in Wuhan, China, in December 2019 [3]. The World Health Organization (WHO) declared COVID-19 as a public health emergency and pandemic in March 2020 [4].

Despite the range of prevention strategies employed to contain the COVID-19 pandemic, over 771.5 million people have contracted the virus, and as of 25 October 2023, more than 6.97 million related deaths had been reported globally [5]. More than 9.55 million COVID-19 cases in Africa and more than 175,443 deaths had been reported as of 25 October 2023 [5]. In Ethiopia, at that date, 501,060 COVID-19 cases and 7,574 deaths related to COVID-19 had been reported [5].

Over the past two decades, improvements in access to antenatal care (ANC) have substantially reduced maternal and neonatal morbidity and mortality in resource-constrained countries [6, 7]. ANC optimises maternal and child health outcomes through regular pregnancy monitoring [8], and provides an opportunity to offer care to prevent and manage existing health complaints and potential causes of maternal and neonatal illness [9]. However, the COVID-19 pandemic may have reversed improvements in ANC utilisation in low- and middle-income countries (LMICs). The pandemic also presents a profound obstacle to implementing the recommended guidelines for improving ANC health service utilisation [9].

In 2016, the WHO recommended a minimum of eight ANC contacts for all pregnant women [10]. Although ANC utilisation had increased during the two decades preceding the pandemic [11, 12], many countries had still not reached the WHO-recommended eight ANC contacts, and women in Ethiopia had fewer ANC contacts than in most other countries. Globally, and in Eastern and Southern Africa, 87% of pregnant women received at least one ANC contact (termed ‘ANC1’), compared to only 74% in Ethiopia. In 2019, the percentage of pregnant women that received at least four ANC contacts (termed ‘ANC4’) was 66% globally, 54% in Eastern and Southern Africa [13], and just 43% in Ethiopia [14].

Since the beginning of the COVID-19 pandemic, ANC utilisation has significantly decreased in (LMICs) [1518] due to fear of contracting the virus [15, 19, 20], lockdowns [21, 22], closure of health institutions [23], lack of transport [24], community fear of health institutions, and delay in healthcare-seeking [21, 25]. Consequently, stillbirths, maternal depression, and maternal deaths have all increased [26].

In the early stage of the COVID-19 pandemic, Ethiopian government, and nongovernmental organisations (NGOs) shifted their focus towards containing the spread of the virus by implementing a range of measures. These measures included declaring a state of emergency, reducing the passenger capacity in public transport by half, imposing a lockdown and encouraging people to stay at home [27]. Consequently, the lockdown measures resulted in job losses for many women [28]. These factors posed significant challenges to women’s ability to meet their basic needs [28]. As a result, the provision of ANC has been and continues to be, impacted by the direct and indirect consequences of COVID-19 [29]. However, the existing studies in Ethiopia on the impact of the COVID-19 pandemic have not rigorously explored its impact on maternity care services, specifically ANC access, uptake, and provision. The paucity of studies on the impact of COVID-19 on ANC access, uptake and provision in Ethiopia made it essential to conduct this study to estimate and explore the impact of COVID-19 on the country’s ANC access, uptake, and provision.

Methods

This study is part of a larger mixed-methods investigation of the impact of COVID-19 on maternal and perinatal care at 15 public hospitals in the Sidama region of southern Ethiopia, carried out between 14 February and 10 May 2022. Sidama is the 10th newly established region in Ethiopia. The region is currently divided into 5 city administrations and 31 administrative divisions, known as ‘Woredas’. In 2019/2020, the region’s total population was 3,983,969, with 1,974,455 males and 2,009,514 females. Sidama has 928,265 women of reproductive age (15–49), 137,845 of whom gave birth in 2019/2020. Regarding healthcare provision, the region has 14 primary hospitals, 3 general hospitals, 1 comprehensive specialised teaching hospital, 123 public health centres, 526 health posts, and over 108 private clinics. Comprehensive emergency obstetric care was available in 15 public hospitals in Sidama during 2020.

Study design and data source

We used a concurrent mixed-methods design [30] incorporating routinely collected quantitative data derived from the health management information system (HMIS) in hospitals [31]. An interrupted time series design was applied for quantitative and an exploratory design for qualitative study. Quantitative and qualitative data were collected in parallel, and the first stage of analysis separately addressed the two types. A further integration phase was conducted to compare and contrast the quantitative and qualitative findings and assess whether they were corroborative or contradictory by making mixed-methods meta-inferences. The integration was conducted by joint display technique [30, 32] (Fig 1).

Fig 1. Concurrent mixed methods research on the impact of COVID-19 on ANC provision was adapted [30].

Fig 1

Data collection methods for quantitative data

Data were collected from all 15 public hospitals providing comprehensive emergency obstetric care in the Sidama region at the time of the study. The sample included all pregnant women who attended ANC in the 12 months before the COVID-19 pandemic (March 2019 to February 2020) and during the six months of the pandemic (March to August 2020), totalling 21,000 women. The first author and research assistants (all with an MSc in clinical midwifery) extracted data from the hospitals’ HMIS. The first case of COVID-19 was officially reported in Ethiopia on 13 March 2020. We used the same months before and during the pandemic to assess the impact of COVID-19 on ANC uptake. Similarly, we included data from March 2019 to February 2020 to evaluate whether ANC was affected by other incidents before COVID-19 and whether these events affected ANC outcomes from March to August 2020.

Quantitative data processing and analysis

After screening the data, any questions regarding data clarity were resolved by revisiting the hospitals and HMIS offices to address any missing data in the provided Excel spreadsheet. Data were imported from Microsoft Excel into Stata version 17 for analysis. We performed an interrupted time series analysis (ITSA) to estimate trends in the uptake of ANC across two periods: before COVID-19 (March 2019 to February 2020) and during COVID-19 (March to August 2020). ITSA can evaluate the impact of population-level interventions, including policy changes and infection prevention programmes, implemented at a clearly defined time [33]. The first official COVID-19 case in Ethiopia was reported on 13 March 2020, so we used this date to mark the start of the intervention period. The mean monthly incidence rate ratio (IRR) of ANC uptake was calculated with a 95% confidence interval (CI), using a Poisson regression model [34, 35] with pre-COVID-19 data as the reference. A Poisson regression model was suitable because the monthly reports of ANC provision comprised count data (non-negative integer values). In ITSA, a Poisson regression model [36] performs better than an autoregressive integrated moving average (ARIMA) model, which is more conventionally used for real-valued time series data. Differences are considered statistically significant at a p-value of less than 0.05 (p < 0.05).

We used a single-group ITSA for this study [35]

Yt=β0+β1Tt+β2Xt+β3XtTt+βmmonth+ϵt

where Yt is the aggregated outcome; β0 estimates the ANC uptake number before COVID-19; β1 estimates the average monthly change in ANC uptake before COVID-19; Tt is the time since the start of the study; β2 represents the change in ANC uptake occurring immediately during the pandemic (within three months) (designated by XtTt); β3 denotes the difference between the trends in ANC uptake before and during COVID-19; and βm represents the month and ϵt the random error.

In this model, time is measured as a dummy variable, taking the value 0 for the period before COVID-19 and 1 for the period during COVID-19 (the intervention period) [35, 37].

Study approach for qualitative data

We adopted an exploratory design [38] to investigate maternity care providers’ views on and experiences of the impact of COVID-19 on ANC provision in the Sidama region. In-depth interviews (IDIs) were conducted with maternity care providers (midwives, obstetric/gynaecology residents, integrated emergency surgical officers [IESOs] and obstetricians/gynaecologists) in private duty rooms and offices in the region’s public hospitals. Four public hospitals were selected for the qualitative study. These four public hospitals (including two primary hospitals, one general hospital and one specialised hospital) were chosen for the qualitative study based on the caseload maternity care services provided and the order in which COVID-19 cases were initially reported in the Sidama region. Three different types of hospitals were selected: primary, general, and one specialised hospital that served as a referral centre for the Sidama region and the surrounding population in the Oromia region. This selection allowed for a nuanced understanding of the impact of the pandemic on various tiers of hospitals and their preparedness, response efficiency and the challenges they faced.

Participant recruitment and sampling technique for qualitative data

Within each chosen hospital, we explained the study’s purpose to the hospital medical director, chief executive director, and maternity care head, seeking their permission to conduct the research. Subsequently, two research assistants (both with an MSc in clinical midwifery) explained the study’s purpose in detail to maternity care providers who volunteered to be interviewed. We used purposive sampling to recruit staff who provided maternity care both before and during the pandemic. All participants provided written informed consent prior to being interviewed. We aimed to recruit approximately 20 participants (10 midwives and 10 obstetricians/gynaecologists). Data reached saturation at 24 interviews. We conducted another four interviews to confirm that data were saturated before ending qualitative data collection.

Collection tools and procedure for qualitative data

We developed a semi-structured interview guide comprising open-ended questions concerning the following factors: availability of and access to maternal and perinatal care; availability of adopted maternal and perinatal care guidelines related to COVID-19; availability of medical supplies and skilled healthcare personnel; and how challenges were overcome. The interview guide was piloted with midwives (N = 4) not included in this study. Two research assistants were recruited to facilitate the IDIs. The first author prepared the interview guide in English and translated it into Amharic, the official language of Ethiopia. In-depth face-to-face interviews were carried out in Amharic by the first author. Each interview was conducted in the maternity care duty room or office when participants were not on duty, and we fully adhered to the Ethiopian government’s COVID-19 prevention policy. The 28 interviews were conducted between 14 February and 10 May 2022, and each was digitally audio-recorded. Interview duration was approximately 30 minutes.

Qualitative data processing and analysis

The audio recordings were transcribed immediately and listened to iteratively. Simultaneously, bilingual researchers transcribed and translated transcripts into English to check consistency. The transcriptions were imported into NVivo software (QSR International, version 12 Plus) to manage the overall data analysis. Thematic analysis [39] was employed to identify, analyse, and report themes and subthemes. We used inductive thematic analysis and followed six phases: phase 1—data familiarisation and writing familiarisation notes; phase 2—systematic coding; phase 3—generating initial themes from coded data; phase four—developing and reviewing themes; phase 5—refining, defining, and naming themes; and phase 6—writing the report [39]. All authors reviewed the themes and subthemes in the thematic analysis phases (from coding to writing a report) and approved the final themes. This study is reported according to the Standards for Reporting Qualitative Research [40] (S1 Table) to ensure that essential details are reported and the thematic analysis is of sufficient quality [41].

Ethics approval and consent to participate

An internal research review board (IRB) at Hawassa University granted ethical clearance, and the University of Technology Sydney ethics committee approved the study with reference number IRB/029/14 (approval no, ETH22-7567) respectively. The research assistants explained the goal and advantages of the research project to each study participant during the data collection process. Before beginning the data collection process, each study participant provided written informed consent. Study participants were also informed of their full right to refuse, withdraw, or reject part or all of their roles in the study. All processes were carried out in accordance with the standards and laws outlined in the Declaration of Helsinki, and data were collected anonymously and kept confidential with the investigators.

Quantitative results: Trends in antenatal care provision in fifteen hospitals

In the 12 months preceding the pandemic, from March 2019 to February 2020, the monthly data from public hospitals in the Sidama region showed a significant increase in uptake of ANC1 and ANC4. Specifically, the monthly estimated incidence rate ratio increased by 1% for ANC1 uptake (IRR = 1.011, 95% CI [1.007, 1.016]; p < 0.0001) and by 2.6% for ANC4 uptake (IRR = 1.026, 95% CI [1.019, 1.033]; p < 0.0001) (Table 1 and Fig 2). In the first three months of the COVID-19 pandemic, when it was at its peak, the monthly estimated incidence of ANC1 uptake decreased by 14% (IRR 0.863, 95%CI 0.812 to 0 .918; P<0.0001), and ANC4 uptake decreased by 14% (IRR 0.858, 95%CI 0.782 to 0.942; P<0.001) (Table 1 and Fig 2). Overall trends during the initial six months of the COVID-19 pandemic revealed that ANC1 uptake significantly decreased by 0.7% (IRR 0.993, 95%CI 0.990 to 0.997; P<0.001) (N = 15,150), and ANC4 uptake significantly decreased by 1.8% (IRR 0.982, 95%CI 0.976 to 0 .987; P<0.0001) (N = 5850) (Table 1 and Fig 2).

Table 1. Trends of ANC provision and availability of essential medications before and during COVID-19 at public hospitals in the Sidama region, March 2019—August 2020.

Trends of ANC provision and availability of essential medication in the hospitals Monthly incidence rate before COVID-19 as an estimated IRR 95% CI P value Monthly incidence rate immediately during the COVID-19 as an estimated IRR 95% CI P value Monthly incidence rate before COVID-19 compared with during COVID-19 as an estimated IRR 95% CI. P value
ANC1 1.011(1.007–1.016) *** 0.0001 0.863 (0.812–0 .918) *** 0.0001 0.993 (0.990–0.997) *** 0.001
ANC4 1.026 (1.019–1.033) *** 0.0001 0.86 (0.78–0.94) *** 0.001 0.982 (0.976–0 .987) *** 0.0001
Overall availability of essential medication in the hospitals 1.00 (0.987–0.1.013) 0.970 1.001 (0.837–1.98) 0.985 0.987(0.0.948–1.029) 0.565
Iron-folic acid tablet (Fefol) 1.207 (0.654−2.229) 0.547 1.006 (0.958−1.056) 0.814 1.003 (0.875− 1.148) 0.971
Magnesium sulfate 0.96 (0.54− 1.73) 0.899 0.99 (0.95−1.038) 0.782 0.99 (0.869− 1.136) 0.925
Oxytocin 1.084 (0.611−1.922) 0.782 1.002 (0.960−1.047) 0.904 0.978 (0.858−1.15) 0.735
Ceftriaxone 1.208 (0.664−2.197) 0.536 1.017 (0.972−1.064) 0.461 0.969 (0.846−1.109) 0.645
Normal saline 1.248 (0.970−2.225) 0.453 1.013 (0.969−1.060) 0.561 0.977 (0.859−1.13) 0.729

Note: * = Significant 0.05

** = Significant at 0.01

*** = Significant at 0.001, IRR = Incidence rate ratio

Fig 2. Mean trends of ANC provision at the Sidama region’s public hospitals in Ethiopia.

Fig 2

Qualitative results: Clinicians views and experiences of the impact of COVID-19 on antenatal care provision

In total, 28 maternity care providers were interviewed face to face: 15 midwives, 2 IESOs, 4 obstetric/gynaecology residents, and 7 obstetricians/gynaecologists (S2 Table). Three themes were constructed from analysis of the data, ‘Barriers to ANC access during the COVID-19’, ‘Barriers to ANC uptake during COVID-19’, and ‘Barriers to ANC provision during the COVID-19’ Fig 3.

Fig 3. Visual representation of thematic analysis.

Fig 3

Three themes were identified, namely, ‘Barriers to ANC access during COVID-19’, ‘Barriers to ANC uptake during COVID-19’, and ‘Barriers to ANC provision during COVID-19’, as displayed in Fig 3. Within these themes, eight subthemes were identified. In the theme of ‘Barriers to ANC access during COVID-19, two subthemes were identified ‘Shortage of resources’, and ‘Community discrimination against those attending the hospital’. Meanwhile in the theme ‘Barriers to ANC uptake during COVID-19’, two subthemes included ‘Fear of contracting COVID-19’, and ‘Decreased attendance of ANC’. Lastly four subthemes were identified in the theme, ‘Barriers to ANC provision during COVID-19’, including ‘Absence of ANC guidelines for care provision’, ‘Inadequate personal protective equipment (PPE)’, ‘COVID-19 vaccine hesitancy’ and ‘Long waiting times for ANC’. The explanations of each theme and subtheme are supported by direct quotes from study participants.

Barriers to ANC access during COVID-19

Two subthemes emerged from our analysis of interview responses relevant to ANC access during COVID-19: ‘Shortage of resources’ and ‘Community discrimination against those attending the hospital’.

Shortage of resources

Participants indicated that a lack of resources during COVID-19 affected women’s access to ANC. In particular, women’s incomes declined, and public transport became more limited and doubled in cost. There was a shift of hospital resources towards COVID-19 prevention and treatment, but a lack of medical supplies, as evidenced by the following quote:

The taxi cost increased during COVID-19, and the women who live in rural areas did not come to the hospital due to transport costs. For example, a woman who came from another city paid double, and she might not come to the hospital [again]’ (Midwife RMP6).

Maternity care providers described how the price of medical supplies substantially increased due to shortages, to the extent that it was impossible for most people to buy them. The combination of Ethiopia’s socio-political situation and the COVID-19 pandemic prevented foreign aid from funding public hospitals, as illustrated by the following quote:

Medical supplies were tough [expensive]; for example, one glove was sold for up to 100 Ethiopian birr [$2 USD]. Foreign aid has decreased due to COVID-19 and the ongoing war in the country. The NGOs donated a lot of supplies [for women’s use] before COVID-19. NGOs ceased contributing medical supplies… no medical supplies in the hospital. Due to the economic crisis, women cannot afford to pay [$2USD] for a single glove’ (IESO ALTP14).

Community discrimination against those attending the hospital

Discrimination by the community against individuals attending the hospital had a detrimental impact on women’s ability to access ANC during COVID-19. Midwives stated that the community discriminated against those who attended hospitals, including both providers and receivers of care. Many community members believed those who visited the hospital could bring the virus to the community. This discrimination also affected healthcare providers, as they could not meet with their families or maintain their daily routines. The discrimination against maternity care providers is illustrated in the following quote:

We [health care providers] could not find food to eat or meet basic needs because of discrimination us in the town. Women and families discriminated against healthcare providers; they did not want us to live with them as we were involved in providing care in the hospital; they believed we could bring COVID-19 to the community, and they think COVID-19 is a killer’ (Midwife MALTP17).

It was a tough time; in my residential area, nurses and physicians could not obtain basic necessities and could not rent a place as a result of discrimination’ (Midwife WR1).

Discrimination resulted in a decline in social capital between healthcare providers and the community, resulting in limited access to ANC As a consequence, COVID-19 further damaged cultural cohesiveness between the community and healthcare providers, as exemplified by the following quote:

Social cohesion between healthcare providers and the community has broken down during COVID-19; for example, we [healthcare providers] could not attend funeral ceremonies. We are confined in the home. We live in a small town; everyone knows the healthcare providers, and they discriminated against us’ (Midwife MLP5).

Midwives reported similar discrimination against women who received care in hospitals. The community discriminated against women who sought any care at the hospital because they believed that anyone visiting the hospital would contract the virus and spread it around. Consequently, this discrimination resulted in limited access to ANC. As one midwife highlighted,

Pregnant women’s rapport with neighbours was affected when they came to [access] care in the hospital during COVID-19. After a [pregnant] woman returned home, her neighbours discriminated against her since she was [accessing] care in the hospital, and her [neighbours] believed she had contracted COVID-19’ (Midwife MAP14).

Barriers to ANC uptake during COVID-19

Two subthemes were identified within ‘Barriers to ANC uptake during COVID-19’ theme: ‘Fear of contracting COVID-19’ and ‘Decreased attendance of ANC’.

Fear of contracting COVID-19

The midwives highlighted that a significant number of women did not attend hospitals because they feared contracting COVID-19. Due to this fear, even women who attended and received care kept their distance from maternity care providers, believing that ‘the hospital was the epicentre of the virus’ (Midwife MRP1). Other midwives concurred:

Women came to [uptake] care in the hospital with fear. They feared healthcare providers. They considered healthcare providers to be a source of COVID-19, ha ha ha’ (Midwife MALTP16).

The women were afraid; as I told you before, they believed that if they came to the hospital for ANC, they would catch COVID-19’ (Midwife MLP5).

Midwives explained that pregnant women’s fear of contracting COVID-19 considerably affected practitioner–client communication during care provision. Maternity care providers felt that this fear prevented them from developing a strong rapport with women or spending sufficient time in consultations. Physical-distance policies stipulated that individuals must remain at least 1.5 metres apart. In addition, because of the perceived risk to their privacy resulting from physical distancing and weakened communication, women were reluctant to disclose their medical information to maternity care providers when attending the hospital. One midwife has the following explanation:

During the pandemic, fear reduced women’s communication with midwives. Women needed to discuss their private [sexual] issues by approaching us [healthcare providers], but distance made it impossible. When women came, we comforted them by touching their shoulders, but now it is not easy. It reduces something that we have had. Furthermore, we would keep our distance from them’ (Midwife MAP12).

Obstetricians and obstetric/gynaecology residents also described how the pandemic disrupted their relationships and communication with women. For fear of spreading the infection, at the peak of COVID-19, none would even touch a woman’s medical chart, and the fetal heartbeat was checked using a Doppler rather than a Pinard fetoscope. One resident commented:

The rapport between women and physicians clearly declined [during COVID-19]. You could not even touch a medical chart when COVID-19 was at its peak because of the news from Italy that physicians had contracted and died from COVID-19. The disease is transmitted by touching a medical chart. There was a great distance. As a result, there was a decline in the rapport between women and physicians. If physicians were doing these things, you might assume other healthcare providers were as well, and many things were missed in giving care’ (Resident 4 RRP10).

Maternity care providers’ rapport with women substantially decreased. For example, before the pandemic, we used Pinard fetoscope to check the fetal heartbeat. Nevertheless, there were numerous concerns about using a Pinard fetoscope to check a fetal heartbeat during the pandemic, so we switched to a Doppler to check the heartbeat. The maternity care providers believed that women with a cough had COVID-19, and so were unwilling to care for them’ (Obstetrician SRP19).

Decreased attendance of ANC

Reporting a decrease in ANC attendance during COVID-19, participants noted that women perceived the hospital as not providing the services and failing to address their needs. In addition, maternity care providers were not actively encouraging women to visit the hospital, leading to recommendations for staying at home, as noted in the following quote:

After Ethiopia reported the first COVID-19 case, maternal health services significantly decreased, and the number of women who came to the hospital, especially for their ANC follow-up, decreased because they were listening to other news about COVID-19 through various media outlets. Many women were staying at home. They believed that the hospital was not providing the services and did not take their needs into consideration when they came’ (IESO ALTP15).

Due to population growth, ANC attendance is expected to grow from one year to the next. However, during COVID-19, obstetricians reported declining daily ANC attendance: ‘women did not come on their appointment day’ (Obstetrician SAP22). One obstetrician expressed an opinion that the decline in ANC attendance was in part due to the messages recommending the community stay at home, and the fact that women were not encouraged to access the services by medical and midwifery staff at the hospital. Further evidence is provided by the following quote:

Before COVID-19, there were around ten women [per day], but during COVID-19, it was around five to seven women. Our population is increasing, but the number of women attending decreased during COVID-19. They came, we treated them, sent them home, and made predictions. As I had predicted, fewer people attended hospitals. According to my predictions, these decreases resulted from the fact that we did not encourage women to attend the hospital …there was a lack of maternity care providers in this hospital’ (Obstetrician SRP24).

Barriers to ANC provision during COVID-19

Four subthemes were identified within the theme ‘Barriers to ANC provision during COVID-19’: ‘Absence of ANC guidelines for care provision’, ‘Inadequate PPE’, ‘COVID-19 vaccine hesitancy’, and ‘Long waiting times for ANC’.

Absence of ANC guidelines for care provision

Participants acknowledged that the availability of ANC guidelines is crucial for providing high-quality care and evidence-based care. Most study participants reported that there were no COVID-19-related ANC guidelines in the hospitals. One obstetrician said, ‘We did not have any protocol… We continued to use the previous obstetric care guidelines’ (Obstetrician SRP 23). While there was some guidance from the WHO on emergency infection prevention, there was no specific protocol for the management of pregnancy care:

There is no unique protocol or approach that we adapted or adopted. The hospital got some aid from the regional health bureau and gave us essential personal protection equipment like gloves, masks, and sanitiser. Using this equipment, we admitted the women who came to the service. However, we did not prepare any COVID-19 protocol or design any strategies at the curriculum level’ (IESO ALTP15).

The WHO developed the guideline and then nationally adopted it. By chance, we have one guideline that was adopted and updated from the previous national guideline in obstetrics in 2020. However, the guideline was not related to COVID-19. Meanwhile, there is a protocol for emergency infection prevention and COVID-19 prevention protocol. It is used for all, including pregnant women. However, specifically, there is no guideline for pregnancy-related care during COVID-19’ (Resident 4 RRP 10).

Inadequate PPE

Midwives indicated that inadequate supplies of COVID-19 PPE were a common problem in hospitals during the pandemic. Maternity care providers noted an imbalance between demand and supply of PPE in the hospitals. The scarcity of ‘facemasks, face shields, shoes and other PPE’ (Midwife MAP 13), perhaps due to increased use of infection control supplies. The following quotes are illustrative:

Five masks were given to each healthcare provider per week, and one sanitiser was given to many healthcare providers, but it was not given individually. [Later] the number of masks was reduced from five to four per week’ (Midwife MALTP17).

Women bought a mask and used it together; when someone left the hospital, they handed it over to another person’ (Midwife MLP5).

COVID-19 vaccine hesitancy

At the time of data collection, only 9 of the 28 participating maternity care providers had received two doses of the COVID-19 vaccination. If maternity care providers are hesitant about the COVID-19 vaccine, it may impact pregnant women’s confidence in the vaccine’s safety and efficacy. This could lead to lower vaccine rates and hinder ANC provision. Some mentioned that they doubted the vaccine’s efficacy or believed that the infection was a punishment for disobeying God’s commandments, as exemplified in the following quote:

I have chosen not to get vaccinated. I do not believe in it, and I do not want the vaccine. My belief is that the outbreak of COVID-19 may be a consequence of our sins was caused by our sins and evil actions. I consider COVID-19 to be a form of divine punishment for our transgressions. Therefore, I believe we should fast and pray in an attempt to avoid this disease’ (Midwife MAP13).

Long waiting times for ANC

Waiting times for ANC provision were longer than usual during COVID-19. Priority was given to women wearing facemasks; hence, those without facemasks had to wait longer. As one midwife commented, ‘The women who wear facemasks get [to access] the service first; those who do not wear facemasks do not get [access to] care’ (Midwife MALTP17). Moreover, maternity care providers were unable to provide the service without face masks, causing delays in providing ANC in hospitals when facemasks were unavailable in the ANC clinic. Women who did not wear facemasks were not permitted to enter ANC clinics or receive immediate care. Despite the decline in ANC attendance, those women who did attend were met with delays in receiving care due to lack of staff, as illustrated by the following quote:

We were nagging patients who did not wear masks, we ordered a woman to wear a mask, and we left the room if she did not wear a facemask. However, we offered ANC during COVID-19 in a manner similar to that before the pandemic; all ANC components were offered during [COVID-19]. Although we performed complete physical examinations…comparable to those performed before COVID-19, the facemask did not bring comfort to women or those who provide maternity care and had a terrible effect during physical examinations’ (Midwife MALTP16).

Many women were waiting [to access] the services, crowded on ANC waiting chairs, and the waiting time was long because [only] one or two maternity care providers gave services. Women were desperate to get [access to] the service, and they [sometimes] returned to their homes without getting healthcare. We [used to provide] ultrasounds for all women during each visit. During COVID-19, we [only] performed ultrasounds for selected women’ (Obstetrician SRP23).

Integrating quantitative and qualitative findings using joint display technique

In the quantitative analysis, monthly trends of ANC attendance and the availability of essential drugs in hospitals were assessed before and during the pandemic. Simultaneously, three themes and eight subthemes were also identified in the qualitative data to explore whether the qualitative findings confirmed or disconfirmed the quantitative findings.

For ANC1 and ANC4 attendance, the quantitative findings revealed decreasing trends during the pandemic, and the qualitative study corroborated these declines, providing evidence that stay-at-home recommendations, lack of (and more expensive) transport, and fear of contracting the virus contributed to reducing the number of women attending hospitals for ANC (Table 2). As one participant commented, ‘the uptake of ANC4 declined due to fear of contracting the virus during COVID-19’ (Midwife MLP5).

Table 2. Joint display of quantitative and qualitative findings for each theme and subtheme on impact of COVID-19 on ANC access, uptake and provision, and mixed-methods meta-inferences.

Theme Subtheme Quantitative findings Qualitative findings Mixed-methods meta-inference
Barriers to ANC access during COVID-19 Shortage of resources Overall trends of availability of essential drugs before and during COVID-19 showed no significant change (IRR = 0.987, 95% CI [0.948, 1.029]; p = 0.565) Maternity care providers demonstrated a shortage of resources, and the women could not afford to buy medical supplies in the hospital while consistently lacking essential medical supplies. The quote below illustrates:
‘There was a shortage of medical supplies during COVID-19; for example, in ANC clinics, iron folic acid and TT vaccine were unavailable’ (IESO ALTP 15).
Contradiction: the discrepancy between quantitative and qualitative findings could be explained by the binary responses (i.e., available or unavailable) in the HMIS form, providing no insight into the exact quantities of essential drugs. By contrast, the qualitative findings explored maternity care providers’ day-to-day experiences of access to essential medical supplies in the hospital. The shortage of essential drugs, such as iron and folic acid, may have caused difficulty for women in accessing ANC.
Community discrimination against those attending the hospital None Maternity care providers reported that women who sought care at a hospital during the pandemic often faced discrimination from the community, which hampered women access to ANC. The quote below illustrates:
There is discrimination. If women went to the hospital, the community assumed they would come back with COVID-19. Women may have been psychologically let down because there was no longer the same social cohesion as before COVID-19 (Midwife MAP14).
The qualitative findings demonstrate that discrimination contributed to reducing ANC access. With a decline in social cohesion, pregnant women feared facing community discrimination after visiting hospital, thus affecting ANC access during COVID-19.
Barriers to ANC uptake during COVID-19 Fear of contracting COVID-19 None Fear of contracting COVID-19 was mentioned as a barrier to the uptake of ANC by maternity care providers. The following quote observes:
‘The outpatient department was not as crowded during COVID-19 as it was before COVID-19 because people stayed home due to fear of contracting the virus’ (Midwife WR1).
The qualitative findings indicated that fear of contracting COVID-19 contributed to reducing ANC uptake. Many pregnant women were more afraid of contracting COVID-19 disease than of suffering pregnancy-related complications, leading to a decline in ANC uptake during the pandemic.
Decreased attendance of ANC Overall trends before and during COVID-19 showed significant reduction of 0.7% in ANC1 provision (IRR = 0.993, 95% CI [0.990, 0.997]; < 0.001), and significant decrease of 1.8% in ANC4 provision (IRR = 0.982, 95% CI [0.976, 0.987]; p < 0.0001) Maternity care providers described a decline in ANC attendance during COVID-19.
‘Pregnant women did not come to their appointments for ANC follow-up. We tried to reinstate ANC follow-up before COVID-19, but they stayed at home; we tried to provide care to them via phone, but it was challenging’ (Obstetrician SAP22).
Corroboration:
the qualitative and quantitative findings indicate that recommendations to stay at home led to pregnant women postponing or cancelling ANC appointments, this reducing ANC uptake during the pandemic.
Barriers to ANC provision during COVID-19 Absence of ANC guidelines for care provision None Maternity care providers reported that no guidelines were introduced for maternal care during the pandemic, notwithstanding ANC appointment changes made by the health bureau.
‘There were no maternal care guidelines related to COVID-19. Meanwhile, appointment intervals were changed by the health bureau’ (Midwife RMP221).
The qualitative findings indicate that the absence of ANC guidelines during COVID-19 reduced the provision of ANC that leading to quality-of-care provision was suboptimal.
Inadequate PPE None Maternity care providers reported that women and healthcare providers used inadequate COVID-19 PPE.
There was a shortage of materials used to prevent COVID-19, for example, soap, hand sanitiser, and masks’ (Midwife MLP5).
The qualitative findings illustrate that inadequate PPE was a barrier to ANC provision. Maternity care providers could not provide optimal ANC without adequate PPE.
COVID-19 vaccine hesitancy None Some maternity care providers mentioned doubts over the efficacy of COVID-19 vaccines, and beliefs that the vaccine causes various diseases, including clotting disorders.
‘It causes blood clotting, cancer, and other issues. There are no diseases more dangerous and fatal than cancer than blood clotting and cancer’ (Midwife MAP14).
The qualitative findings demonstrate that COVID-19 vaccine hesitancy impacted ANC provision. Such hesitancy in maternity care providers could have increased the reluctance of pregnant women to be vaccinated, since the providers would not attempt to persuade them of the vaccine’s benefits during pregnancy.
Furthermore, vaccine-hesitant maternity care providers’ fear of contracting the virus when providing ANC could have further reduced ANC provision.
Long waiting times for ANC None Maternity care providers commented that women faced long waiting times for ANC during the pandemic, especially if they did not wear a mask.
‘The women who wear facemasks get [to access] the service first; those who do not wear facemasks do not get [to access] care until they bought and wore a mask’ (Midwife MALTP17).
The qualitative findings illustrate that long waiting times hindered ANC provision during COVID-19. Maternity care providers could not allow care to pregnant women until they wore a facemask, leading to reduced ANC provision during the pandemic.

By contrast, the quantitative and qualitative findings on essential drug availability were contradictory (Table 2). The quantitative analysis showed no significant difference in the availability of essential drugs in hospitals before and during the pandemic. However, access was impacted for women by the cost, and according to staff, by supply shortages, as the following quote demonstrates, ‘medical supplies decreased in the hospital, and the cost of medical supplies increased. All things were going up during the COVID-19 pandemic’ (IESO ALTP14). The same discrepancy was found for iron and folic acid availability, which did not significantly differ between before and during the pandemic according to the quantitative analysis but notably declined according to the qualitative analysis: ‘pregnant women faced challenges in accessing and taking iron-folic acid supplement appropriately during the pandemic’ (Midwife MALTP18). These inconsistencies could be explained by inadequacies in the HMIS inventory. The binary nature of data in the HMIS form means that responses are limited to ‘available’ or ‘unavailable’, with no space to include details of the quantities of essential drugs. Hence, the HMIS data do not adequately represent the scenario on the ground at the hospital pharmacy level (Table 2).

There is a lack of data to demonstrate quantitatively whether ANC guidelines are in place, the amount of PPE equipment available or vaccine rates to confirm qualitative findings. Additionally, there is no data to determine wait times for ANC, presence and severity of fear of contracting COVID-19, or measures of discrimination from the community. This information reported by care providers is similarly reported in the literature for other comparable countries (Table 2).

Discussion

Understanding the difficulties of access to ANC during any disease outbreak is essential to ensuring and sustaining ANC services [42]. This understanding aids in the identification of specific barriers within both the community and the healthcare system during a crisis, providing opportunities to mitigate their indirect consequences. This study demonstrated that access to ANC was disrupted due to a shortage of resources and discrimination against those attending the hospital during COVID-19. These findings are consistent with a systematic review conducted in three West African countries during the Ebola outbreak [43], showing that disruption to ANC access during the Ebola outbreak was the result of community mistrust of the health facilities and discrimination against those who attended and provided ANC in the health facilities. Such disruptions could lead to a weakened coherence between the community and healthcare providers. A qualitative study in rural India found that ANC access was limited in the first wave of COVID-19 by lockdown restrictions and a prevailing sense of mistrust in the public health system and its functioning [42]. A studies in Kenya, Nigeria and India [15, 21, 24, 25] align with this findings that ANC access was restricted by lack of transport or inability to afford it, inability to pay for medical expenses, and the closure of non-essential services during the pandemic.

Quantitative findings showed that the availability of essential medical supplies before and during COVID-19 remained stable. The qualitative study, however, revealed that most study participants observed a shortage of essential medical supplies. Before COVID-19, maternity care providers reported that all pregnant women received care without any charge and were supplied with essential supplements. For over a decade, a pillar of the Ethiopian government’s programme to reduce maternal and neonatal mortality rates was the provision of free care to pregnant women and newborns in public health facilities. This had made a significant impact in lowering maternal and neonatal mortality, but the additional burden of COVID-19 is a possible threat to the free care that supported this progress. The burden on the health system resulting from the pandemic might raise the costs and demand for medical supplies, for example, increased usage of PPE, gloves, essential drugs, and increased prices, triggering an economic downturn that could continue to affect ANC access [44, 45].

The challenges of accessing ANC during the pandemic resulted in decreased uptake, consequently reducing the proportion of women obtaining at least a minimal level of evidence-based, routine ANC and management of complications during ANC at healthcare facilities. In 2016, the WHO recommended that pregnant women have at least eight ANC contacts with maternity care providers throughout their pregnancy [46]. Prior to the pandemic, Ethiopia had only recently implemented this guideline and was struggling to increase ANC4 coverage. The unprecedented impact of COVID-19 has placed a double burden on the country’s maternal healthcare system, directly and indirectly affecting ANC uptake.

This study found that during the first six months of the pandemic, mean monthly incidence rates of ANC1 and ANC4 uptake declined considerably. These quantitative findings were corroborated by the qualitative findings. According to maternity care providers, women’s attendance for ANC follow-up fell at the COVID-19 peak in April 2020. Maternity care providers demonstrated that women’s fears of contracting either virus were a barrier to ANC uptake. These findings also align with a literature review from three West African countries [47], and a qualitative study exploring how the fear of contracting Ebola [48] hindered the uptake of ANC.

Our findings demonstrate that the lack of ANC guidelines, long waiting times, inadequate PPE, and COVID-19 vaccine hesitancy affected ANC provision during the pandemic. These findings coincide with the results of a study in Nigeria [24], which showed that long waiting times, shortages of medical supplies and human resources, and healthcare providers’ lack of preparedness were barriers to ANC provision during the first wave of COVID-19.

In this study, maternity care providers explained that during the pandemic, there were no guidelines adapted to the provision of ANC and intrapartum care in hospitals during COVID-19. However, revised guidelines for the national comprehensive COVID-19 clinical management handbook [49] were issued in 2020. This updated protocol placed more emphasis on the management of COVID-19-suspected and confirmed pregnant women during ANC and intrapartum care.

In addition, the existing obstetric management protocol guidelines for hospitals were revised and issued in 2021 [50]. While these updated hospital protocols address ANC and intrapartum care, they do not make explicit recommendations for service delivery during a pandemic. This finding is inconsistent with a study in LMICs that showed how ANC guidelines were adopted and locally tailored for familiarisation by maternity care providers to preserve and improve the provision of ANC during COVID-19 [18]. However, another global cross-sectional study of 714 maternal and neonatal professionals, 39% of whom were in LMICs, found that 53% of study participants received no updated guidelines during the pandemic [51].

In this study, participants indicated that a shortage of PPE supplies during the pandemic made it difficult to provide ANC. These findings corroborate the results of a study in Nigeria, which found that a lack of PPE inhibited maternity care provision [24]. A lack of COVID-19 prevention materials in hospitals could have reduced the rapport between pregnant women and maternity care providers. According to participants, there were frequent shortages of non-pharmaceutical prevention supplies, including facemasks, PPE, gloves, face shields, and sanitisers. This finding coincides with a study in Nepal [52] found that lack of PPE affected ANC provision.Our results also align with the findings of a global survey exploring how wearing facemasks affected gesture communication and facial expressions between patients and healthcare providers [51].

Vaccine hesitancy among healthcare providers is a factor in preventing greater coverage of population immunity and affecting the provision of ANC. Mistrust of the COVID-19 vaccine was expressed by maternity care providers in this study. A cross-sectional study conducted in Nigeria [53] and Egypt [54] showed that respectively, 50.5% and 42% of healthcare workers exhibited vaccine hesitancy. Vaccine hesitancy may have been related to healthcare providers’ fears of adverse effects in their future pregnancies and other medical complications, efficacy uncertainty, inadequate vaccine trials prior to human administration, doubts about vaccine benefits, misinformation and disinformation about the vaccine’s side effects [55].

Participating maternity care providers reported the limited availability of iron and folic acid during the pandemic. This is consistent with the finding of a study conducted in Northwest Ethiopia exploring the unavailability in hospitals of ferrous sulphate 150 mg + folic acid 0.5 mg tablets, which are routinely prescribed to pregnant women for at least three months in areas where iron deficiency anaemia is common [56].

Our findings showed that the shocking declines in ANC uptake and provision reinstated after four months. This could be attributed to the actions of the Minister of Health, who implemented various strategies to ensure the continuation and maintenance of essential services, including raising the number of healthcare providers at health facilities and establishing a non-COVID-19 task force to reverse the decline in ANC attendance [57]. Hospitals also carried out home visits and made phone calls to pregnant women with registered phone numbers in order to boost ANC uptake among pregnant women.

The strength of our study lies in our mixed-methods approach and collection of data from 15 public hospitals across the Sidama region. We explored the perceptions of a diverse range of maternity care providers through IDIs.

However, the study also has limitations. Quantitative data were obtained from the HMIS, an administrative data source that could contain inaccuracies: it is possible that relevant data were overestimated or underreported, especially in the absence of population-level denominators. Staffing issues during the pandemic might have impacted the accuracy of HMIS reporting. Since our study primarily examines hospital-level data, further research is needed to assess ANC access, uptake, and provision at primary health centres.

Conclusion and recommendations

Our findings demonstrate that the COVID-19 pandemic affected ANC access, uptake, and provision in the study area from March to August 2020. To mitigate disrupted ANC access, uptake and provision, ANC clinics should be equipped with medical supplies. It is crucial to maintain rapport between the community and maternity care providers and provide training for maternity care providers regarding the adapted/adopted guidelines during COVID-19 at the hospital grassroots level for use in the current and future pandemics. Pregnant women should have access to timely care from maternity care providers, to maintain at least a minimum standard of care in the current and future pandemics. Further studies are needed to understand the long-term impact of COVID-19 on ANC access, uptake, and provision, as well as the impact on these factors of internal conflict within Ethiopia.

Supporting information

S1 Table. Standards for Reporting Qualitative Research (SRQR).

(DOCX)

pone.0301994.s001.docx (27KB, docx)
S2 Table. Sociodemographic characteristics of study participants (N = 28).

(DOCX)

pone.0301994.s002.docx (17.7KB, docx)

Acknowledgments

First, we would also like to thank study participants, health bureau officials, HMIS data managers and hospital chief executive directors for cooperating during the study. The author would like to acknowledge Dr Caroline Havery for her help with English grammar.

List of abbreviations

ANC

Antenatal care

ARIMA

Autoregressive integrated moving average

CEmOC

Comprehensive emergency obstetric care

COVID-19

Coronavirus disease 2019

HMIS

Health management information system

IDI

In-depth interview

IESO

Integrated emergency surgical officer

IRR

Incidence rate ratio

ITS

Interrupted the time series

NICU

Neonatal intensive care unit

PPE

Personal protective equipment

SDG

Sustainable development goal

WHO

World Health Organization

Data Availability

Data Availability Statement: The interview data cannot be shared publicly since it contains potentially attributable sensitive information regarding participants and their roles. Sharing such data would violate and undermine the ethical committee agreement and consent process. Researchers who meet the criteria for access to confidential data may request it from the University of Technology Sydney Human Research Ethics Committee at Research.Ethics@uts.edu.au. All other relevant data are presented within the paper.

Funding Statement

The Royal Society of Tropical Medicine and Hygiene is supported financially for only data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. doi: 10.1016/j.jaut.2020.102433 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199–207. doi: 10.1056/NEJMoa2001316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sharma A, Tiwari S, Deb MK, Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents. 2020;56(2):106054. doi: 10.1016/j.ijantimicag.2020.106054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March Geneva, Switzerland; 2020. [Google Scholar]
  • 5.WHO. Weekly Epidemiological Update on COVID-19, 25 October. 2023. [Google Scholar]
  • 6.Shiferaw K, Mengiste B, Gobena T, Dheresa M. The effect of antenatal care on perinatal outcomes in Ethiopia: A systematic review and meta-analysis. PLoS One. 2021;16(1):e0245003. doi: 10.1371/journal.pone.0245003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Berhan Y, Berhan A. Antenatal care as a means of increasing birth in the health facility and reducing maternal mortality: a systematic review. Ethiopian Journal of Health Science. 2014;24 Suppl(0 Suppl):93–104. doi: 10.4314/ejhs.v24i0.9s [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Muluneh AA, Kassa ZY, Mamo ZB, Hadra N. Utilization of antenatal care and associated factors in Gedeo zone, Southern Ethiopia,Ethiopian Journal of Reproductive Health (EJRH) January. 2021;13(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Menendez C, Gonzalez R, Donnay F, Leke RGF. Avoiding indirect effects of COVID-19 on maternal and child health. Lancet Global Health. 2020;8(7):e863–e4. doi: 10.1016/S2214-109X(20)30239-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. World Health Organization; 2016. Report No.: 9241549912. [PubMed] [Google Scholar]
  • 11.Duodu PA, Bayuo J, Mensah JA, Aduse-Poku L, Arthur-Holmes F, Dzomeku VM, et al. Trends in antenatal care visits and associated factors in Ghana from 2006 to 2018. BMC Pregnancy Childbirth. 2022;22(1):59. doi: 10.1186/s12884-022-04404-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tsegaye S, Yibeltal K, Zelealem H, Worku W, Demissie M, Worku A, et al. The unfinished agenda and inequality gaps in antenatal care coverage in Ethiopia. BMC Pregnancy Childbirth. 2022;22(1):82. doi: 10.1186/s12884-021-04326-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.UNICEF. Antenatal care. 2019. [Google Scholar]
  • 14.EPHI. Ethiopia mini demographic and health survey: key indicators. 2019. [Google Scholar]
  • 15.Landrian A, Mboya J, Golub G, Moucheraud C, Kepha S, Sudhinaraset M. Effects of the COVID-19 pandemic on antenatal care utilisation in Kenya: a cross-sectional study. BMJ Open. 2022;12(4):e060185. doi: 10.1136/bmjopen-2021-060185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Asuming PO, Gaisie DA, Agula C, Bawah AA. Impact of Covid-19 on Maternal Health Seeking in Ghana. Journal of International Development. 2022;34(4):919–30. doi: 10.1002/jid.3627 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Doubova SV, Leslie HH, Kruk ME, Pérez-Cuevas R, Arsenault C. Disruption in essential health services in Mexico during COVID-19: an interrupted time series analysis of health information system data. BMJ Global Health. 2021;6(9). doi: 10.1136/bmjgh-2021-006204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Aranda Z, Binde T, Tashman K, Tadikonda A, Mawindo B, Maweu D, et al. Disruptions in maternal health service use during the COVID-19 pandemic in 2020: experiences from 37 health facilities in low-income and middle-income countries. BMJ Global Health. 2022;7(1). doi: 10.1136/bmjgh-2021-007247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.das Neves Martins Pires PH, Macaringue C, Abdirazak A, Mucufo JR, Mupueleque MA, Zakus D, et al. Covid-19 pandemic impact on maternal and child health services access in Nampula, Mozambique: a mixed methods research. BMC Health Services Research. 2021;21(1):860. doi: 10.1186/s12913-021-06878-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Watson G, Pickard L, Williams B, Hargreaves D, Blair M. ’Do I, don’t I?’ A qualitative study addressing parental perceptions about seeking healthcare during the COVID-19 pandemic. BMJ Archive Disease in Childhood. 2021;106(11):1118–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Goyal M, Singh P, Singh K, Shekhar S, Agrawal N, Misra S. The effect of the COVID-19 pandemic on maternal health due to delay in seeking health care: Experience from a tertiary center. Int J Gynaecol Obstet. 2021;152(2):231–5. doi: 10.1002/ijgo.13457 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Burt JF, Ouma J, Lubyayi L, Amone A, Aol L, Sekikubo M, et al. Indirect effects of COVID-19 on maternal, neonatal, child, sexual and reproductive health services in Kampala, Uganda. BMJ Global Health. 2021;6(8). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Babalola OJ, Sesay HW, Blebo LS, Whesseh FK, Umeokonkwo CD, Adewuyi PA, et al. The influence of first wave of COVID-19 outbreak on routine healthcare services, Liberia, August 2020: a mixed study approach. BMC Health Services Research. 2022;22(1):684. doi: 10.1186/s12913-022-08074-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Akaba GO, Dirisu O, Okunade KS, Adams E, Ohioghame J, Obikeze OO, et al. Barriers and facilitators of access to maternal, newborn and child health services during the first wave of COVID-19 pandemic in Nigeria: findings from a qualitative study. BMC Health Services Research. 2022;22(1):611. doi: 10.1186/s12913-022-07996-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Leung C, Olufunlayo T, Olateju Z, MacArthur C, Taylor B. Perceptions and experiences of maternity care workers during COVID-19 pandemic in Lagos State, Nigeria; a qualitative study. BMC Health Services Research. 2022;22(1):606. doi: 10.1186/s12913-022-08009-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chmielewska B, Barratt I, Townsend R, Kalafat E, van der Meulen J, Gurol-Urganci I, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Global Health. 2021;9(6):e759–e72. doi: 10.1016/S2214-109X(21)00079-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Huluka DK, Ashagrie AW, Gebremariam TH, Ahmed HY, Kebede RA, Binegdie AB, et al. Strategic response to COVID-19 in Ethiopia. Public Health Action. 2022;12(4):191–4. doi: 10.5588/pha.22.0007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Angaw KW. Policy Responses and Social Solidarity Imperatives to Respond the COVID-19 Pandemic Socioeconomic Crises in Ethiopia. ClinicoEconomics and Outcomes Research 2021;13:279–87. doi: 10.2147/CEOR.S300695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Abagero A, Ragazzoni L, Hubloue I, Barone-Adesi F, Lamine H, Addissie A, et al. A Review of COVID-19 Response Challenges in Ethiopia. Int J Environ Res Public Health. 2022;19(17). doi: 10.3390/ijerph191711070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Creswell JW. A concise introduction to mixed methods research: SAGE publications; 2014. [Google Scholar]
  • 31.Biru A, Birhan D, Melkamu G, Gebeyehu A, Omer AM. Pathways to improve health information systems in Ethiopia: current maturity status and implications. Health Res Policy Syst. 2022;20(1):78. doi: 10.1186/s12961-022-00860-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Fetters MD. The mixed methods research workbook: Activities for designing, implementing, and publishing projects: Sage Publications; 2019. [Google Scholar]
  • 33.Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348–55. doi: 10.1093/ije/dyw098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Imrey PB. Poisson regression, logistic regression, and loglinear models for random counts. Handbook of applied multivariate statistics and mathematical modeling: Elsevier; 2000. p. 391–437. [Google Scholar]
  • 35.Linden A. Conducting interrupted time-series analysis for single-and multiple-group comparisons. The Stata Journal. 2015;15(2):480–500. [Google Scholar]
  • 36.Quddus MA. Time series count data models: an empirical application to traffic accidents. Accident Annalysis and Prevention. 2008;40(5):1732–41. doi: 10.1016/j.aap.2008.06.011 [DOI] [PubMed] [Google Scholar]
  • 37.Delamou A, Ayadi AME, Sidibe S, Delvaux T, Camara BS, Sandouno SD, et al. Effect of Ebola virus disease on maternal and child health services in Guinea: a retrospective observational cohort study. Lancet Global Health. 2017;5(4):e448–e57. doi: 10.1016/S2214-109X(17)30078-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Colorafi KJ, Evans B. Qualitative Descriptive Methods in Health Science Research. Health Environments Research & Design (HERD). 2016;9(4):16–25. doi: 10.1177/1937586715614171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Clarke V, Braun V. Thematic analysis: a practical guide. Thematic Analysis. 2021:1–100. [Google Scholar]
  • 40.O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245–51. doi: 10.1097/ACM.0000000000000388 [DOI] [PubMed] [Google Scholar]
  • 41.Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qualitative research in psychology. 2021;18(3):328–52. [Google Scholar]
  • 42.Bankar S, Ghosh D. Accessing Antenatal Care (ANC) services during the COVID-19 first wave: insights into decision-making in rural India. BMC Reproductive Health. 2022;19(1):158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kassa ZY, Scarf V, Fox D. The effect of Ebola virus disease on maternal health service utilisation and perinatal outcomes in West Africa: a systematic review. BMC Reproductive Health. 2022;19(1):35. doi: 10.1186/s12978-022-01343-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Hailemariam S, Agegnehu W, Derese M. Exploring COVID-19 Related Factors Influencing Antenatal Care Services Uptake: A Qualitative Study among Women in a Rural Community in Southwest Ethiopia. Journal of Primary Care and Community Health. 2021;12:2150132721996892. doi: 10.1177/2150132721996892 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kayiga H, Genevive DA, Amuge PM, Ssemata AS, Nanzira RS, Nakimuli A. Lived experiences of frontline healthcare providers offering maternal and newborn services amidst the novel corona virus disease 19 pandemic in Uganda: A qualitative study. PLoS One. 2021;16(12):e0259835. doi: 10.1371/journal.pone.0259835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.WHO. WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience Geneva: World Health Organisation Copyright © World Health Organization.; 2016. [PubMed] [Google Scholar]
  • 47.Yerger P, Jalloh M, Coltart CEM, King C. Barriers to maternal health services during the Ebola outbreak in three West African countries: a literature review. BMJ Global Health. 2020;5(9). doi: 10.1136/bmjgh-2020-002974 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Massaquoi H, Atuhaire C, Chinkonono GS, Christensen BN, Bradby H, Cumber SN. Exploring health-seeking behavior among adolescent mothers during the Ebola epidemic in Western rural district of Freetown, Sierra Leone. BMC Pregnancy Childbirth. 2021;21(1):37. doi: 10.1186/s12884-020-03521-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ethiopian Ministry of Health. National Comprehensive COVID-19 Clinical Management Handbook for Ethiopia. 2020. September,2020. [Google Scholar]
  • 50.Ethiopian Ministry of Health. Obstetrics management protocol for hospitals. Federal Ministry of Health Addis Ababa; 2021. [Google Scholar]
  • 51.Semaan A, Audet C, Huysmans E, Afolabi B, Assarag B, Banke-Thomas A, et al. Voices from the frontline: findings from a thematic analysis of a rapid online global survey of maternal and newborn health professionals facing the COVID-19 pandemic. BMJ Global Health. 2020;5(6). doi: 10.1136/bmjgh-2020-002967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Thapaliya B, Yadav SK, Bhattarai S, Giri S, Sapkota S, Arjyal A, et al. Health worker perspectives on access to antenatal care in rural plains Nepal during the COVID-19 pandemic. PLoS One. 2023;18(4):e0284796. doi: 10.1371/journal.pone.0284796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Amuzie CI, Odini F, Kalu KU, Izuka M, Nwamoh U, Emma-Ukaegbu U, et al. COVID-19 vaccine hesitancy among healthcare workers and its socio-demographic determinants in Abia State, Southeastern Nigeria: a cross-sectional study. Pan Afr Med J. 2021;40:10. doi: 10.11604/pamj.2021.40.10.29816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.El-Sokkary RH, El Seifi OS, Hassan HM, Mortada EM, Hashem MK, Gadelrab M, et al. Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study. BMC Infectious Diseases. 2021;21(1):762. doi: 10.1186/s12879-021-06392-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Hossain MS, Islam MS, Pardhan S, Banik R, Ahmed A, Islam MZ, et al. Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study. PLoS One. 2022;17(8):e0269944. doi: 10.1371/journal.pone.0269944 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Tefera BB, Tafere C, Yehualaw A, Mebratu E, Chanie Y, Ayele S, et al. Availability and stock-out duration of essential medicines in Shegaw Motta general hospital and Motta Health Centre, North West Ethiopia. PLoS One. 2022;17(9):e0274776. doi: 10.1371/journal.pone.0274776 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Ethiopian Ministry of Health. Implementation guide for non-covid-19 essential health services in Ethiopia during the COVID-19 pandemic. 2020 25/01/2023. [Google Scholar]

Decision Letter 0

Ephraim Kumi Senkyire

1 Jun 2023

PONE-D-23-07658Impact of COVID-19 on antenatal care provision at public hospitals in Ethiopia: a mixed method studyPLOS ONE

Dear Dr. Kassa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Major revision of your manuscriptis require before further consideration. Psy atten to reviewer 2 comments and make appropriate corrections.

Please submit your revised manuscript by Jul 16 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ephraim Kumi Senkyire

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

   "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. 

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the good work.

1. the first theme is described as "the impact of ANC access"........I hope it is a typing error and better to write it as" access to ANC or the impact of COVID-19 on ANC access...."

2. please remove the last row in Table 3(Joint display of quantitative, qualitative and mixed methods results ...)

Reviewer #2: Comments

Thank you for your invitation to review this paper. Here are comments listed below:

Title

The study is already over searched, Even a systematic review of metanalaysis have been done in Ethiopia entitled with <impact a="" and="" covid-19="" essential="" ethiopia:="" healthcare="" in="" maternal="" metaanalysis="" of="" on="" pandemic="" review="" services="" systematic="" utilization=""> or link https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281260#:~:text=Impact%20of%20COVID%2D19%20pandemic%20on%20ANC%20services,CI%3A%2015.85%2C%2022.76) . So what you added to your finding?

The title should be rewrite in SMART form meaning that mainly it should clear where (specifically for local reader better to add < Sidam Region, Ethiopia> and when the study done.

Abstract

Methods section

What is the exact data collection period? What is your sample size? It is not clear to the reader. The author collect data before covid 19 (March 2019 to February 2020), so how to relate the study with covid 19?

Result

No information mentioned about the quantitative data in your result. So please include them.

Conclusion

Authors should be selective to generalize the whole finding what they have gotten from the finding. It is not clear that why the authors select only three views (ANC access, uptake and provision) for conclusion?

Keywords

The author should select MESH terms for key word selection.

Introduction

The first sentence needs citation–page 2, line49-50

Please avoid the use of reference repeatedly. E.g. reference 1, 3, etc. repeated more than two times.

Page 3 line 69, insert citation of reference (9) at the end of sentence.

Methods

Please Rewrite as <methods and="" materials="">

Setting

All information presented here are mentioned in the methods section. So please try to merge it or delete one them since in scientific paper writing form no need of redundancy.

What are your study settings/institutions? It is not clearly stated, and try to focus on your study area and selected settings.

Quantitative methods

Setting

Please rewrite the whole paragraph of this section. No need of writing unnecessary information in study setting like the first sentence you wrote about study design <we an="" implemented="" interrupted="" series="" time="">.

Sample size not determined. Why?

Data processing and analysis

It lacks focus. It should describe about data entry and analysis, but not data collection methods, data collection procedures etc.

Qualitative methods

Please omit redundancy. Your method part is not clear as a whole. You have three section methods in this document (methods, quantitative methods, and Qualitative methods). You should have one comprehensive methods or a max of two sections of methods.

Study participant recruitment and sampling technique

Who is your research assistant? Please clearly mentioned them

What are your study participants? Patient or health care provider

Why the authors used a purposive sampling technique? Is that good to use non probable sampling methods to write scientific papers important for scientific evidence? In my view it is not acceptable.

Please insert this sentence in <participants being="" consent="" informed="" interviewed="" prior="" provided="" to="" written=""> in Ethical approval and consent section.

What about Study participant recruitment and sampling technique of quantitative methods??

Data collection tools and procedure

No information mentioned here that describe about the data collection instrument/ tool you used in measurable way. Where the questionnaire you adapted or adopted? Is the too you used is valid or not? If valid what is its validity and reliability test value?

Data processing and analysis

It seems only qualitative study design study. What about Data processing and analysis of quantitative section?

Results

Trends in antenatal care provision in fifteen hospitals

Where you have got IRR 1.1%? Please revise it (1%). Line 227

Qualitative results

Please rewrite the participants’ response in quotation form.

Where is the result of the quantitative part? You have mentioned only the qualitative and joint result. Please add the missed section.

Discussion

Try to discuss both the quantitative and qualitative findings.

Please revise and rewrite in two side comparative form.

Conclusion

Replaced conclusion with < conclusions and recommendations>

Try to focus on your finding

e.g. You recommended <additional are="" country="" factors="" impact="" in="" long-term="" needed="" on="" ongoing="" studies="" the="" these="" to="" understand="" war="">. It is out of your scope of study/title.

As a whole please try to contact English language expertise and revise the grammar, punctuation, syntax etc. of the entire document to be clear, easily understandable to the readers.</additional></participants></we></methods></impact>

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Comments.docx

pone.0301994.s003.docx (15.3KB, docx)
PLoS One. 2024 Apr 18;19(4):e0301994. doi: 10.1371/journal.pone.0301994.r002

Author response to Decision Letter 0


16 Jul 2023

Dear reviewers,

Thank you for taking the time to review our manuscript and for your constructive comments and suggestions, which are vital to improving the quality of the manuscript. We addressed your comments point by point, provided clarifications, and incorporated your suggestion into the manuscript as follows:

Reviewer 1 comments Thank you for the good work.

1. the first theme is described as "the impact of ANC access"........I hope it is a typing error and better to write it as" access to ANC or the impact of COVID-19 on ANC access...."

Authors response

Thank you for your comment, the revision has been made in line 52, page 3.

The impact of COVID-19 on ANC access

2. please remove the last row in Table 3 (Joint display of quantitative, qualitative and mixed methods results ...)

Authors response

We understand your concern; however, the last row in Table 3 shows the argument about whether qualitative findings support the quantitative findings and, if yes, how and if not, why. We modified the arguments and rigorously explained the confirmation and disconfirmation between quantitative and qualitative findings in Table 3.

Reviewer 2 comments

1. The study is already over-researched, even a systematic review of meta-analysis has been done in Ethiopia entitled with <Impact of COVID-19 pandemic on utilisation of essential maternal healthcare services in Ethiopia: A systematic review and meta-analysis> or Link

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281260

So, what you added to your finding?

Authors response

Dear reviewer, we appreciate your concern regarding the over-researched issue related to our study. To the best of our search and knowledge, no study is exploring the impact of COVID-19 on ANC access, uptake, and provision in a rigorous method. Included studies in this systematic review and meta-analysis (the link you provided) and other studies used the impact of COVID-19 on ANC utilisation; however, they are quite different. The detailed difference between our study and other studies conducted in Ethiopia is as follows:

1. Most of the studies do not show ANC access, uptake, and provision before and during the pandemic. However, they showed ANC uptake during the pandemic without comparing it to before the pandemic, and they did not explore the impact of COVID-19 on ANC access, uptake, and provision.

2. There are also methodological differences; the current study differs from previously published studies on the analysis model employed in the quantitative study and integration of quantitative and qualitative findings. Hence, previously published studies employed a binary logistic regression model, Paired t-test and non-parametric (Wilcoxon signed-rank) tests to estimate the trends of ANC uptake before and during the pandemic. However, the current study used interrupted time series analysis to estimate the trend of ANC uptake before and during the pandemic based on the recommendations from three biostatisticians. As described in the methods section of this paper, the rationale for using the interrupted time series analysis is found in lines 148-151 of page 6. Interrupted time series analysis is a robust statistical analysis method that recommends evaluating the impact of population-level interventions, including policy changes, infection prevention programmes, and pandemics like COVID-19 that have been experienced at a clearly defined time.

3. As described in lines 154-155, page 6, we used the Poisson regression model because the outcome of interest is count data. Furthermore, in the current study, we controlled seasonal and other incidents' effects during the analysis.

4. We used Braun and Clarke’s thematic analysis approach using NVivo 12 plus, which followed six phases to identify themes in our qualitative study. This has not been conducted in previously published articles from Ethiopia.

5. Our qualitative findings explored the impact of COVID-19 on ANC access, uptake, and provision in a rigorous method, while previous studies did not rigorously explore the impact of COVID-19 on ANC access, uptake, and provision independently.

6. We integrated the quantitative and qualitative findings in a joint display analysis based on the recommendations from John W. Creswell’s book (2014) and Fetters MD (2019), which showed three types of integration for concurrent mixed methods- study data transformation, joint display technique and side-by-side (weaving) in the discussion section. In this study, we used the joint display approach, presented in Table 3; however, previous studies do not indicate which integration approach was used in concurrent mixed methods study.

7. In summary, the above justifications clearly show the difference between our current study from previously published works in the same area in Ethiopia. This study contributes to the body of evidence about critical issues and how stakeholders can maintain and enhance ANC access, uptake, and provision for future health systems in crisis related to the epidemic, pandemic, and any natural and man-made disaster. Additionally, this study adds to the body of knowledge and aims to contribute vital evidence to inform the planning and management of future population-level disasters (including epidemic/pandemic situations).

2. The title should be rewrite in SMART form meaning that mainly it should clear where (specifically for local reader better to add < Sidam Region, Ethiopia> and when the study done.

Authors response

Thank you for your comment, the revision has been made in line 1, page 1.

Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed method study

Abstract

3. Methods section

What is the exact data collection period?

Authors response

Thank you for your comment, the revision has been made in lines 30-31, page 2.

A concurrent mixed methods study was applied between 14 February 2022 and 10 May 2022 at fifteen public hospitals in the Sidama region.

4. What is your sample size? It is not clear to the reader.

Authors response

Thank you for your comment. Interrupted time series design focuses on any change or difference in a specific time interval due to interventions such as policy change or any disease outbreak. In our case, monthly ANC uptake significantly differs before and during the pandemic (the pandemic is considered an intervention). In our quantitative study, there is a lack of population-level denominators, and we described it as a limitation. The revision has been made in lines 31-35, page 2.

This study included all pregnant women who uptake ANC before COVID-19 (12 months from March 2019 to February 2020) and during COVID-19 (six months from March 2020 to August 2020) at fifteen public hospitals in the Sidama region. The total number for the ANC1 cohort was 15,150, and 5,850 for the ANC4 cohort. The final dataset amounted to 21,000 women, and 28 maternity care providers were interviewed.

5. The author collect data before covid 19 (March 2019 to February 2020), so how to relate the study with covid 19?

Author response

We appreciate your concern, and our objective is to estimate the monthly attendance of women for ANC at public hospitals by comparing before and during the pandemic. This allowed us to assess monthly trends of ANC attendance and control for seasonal and other influencing effects. We extracted data from HMIS at 15 public hospitals for the monthly report before COVID-19 (March 2019 to February 2020) and during COVID-19 from March to August 2020 to estimate monthly trends of ANC uptake before and during the pandemic. As described in lines 38-41, page 2.

We used routinely collected data derived from the health management information system (HMIS) in fifteen hospitals in the Sidama region, Ethiopia. Monthly data were collected from March 2019 to February 2020 (12 months) before COVID-19 and from March to August 2020 (6 months) during COVID-19.

6.Result

No information mentioned about the quantitative data in your result. So please include them.

Author response

Thank you for your comment, the revision has been made in lines 49-51, pages 2 & 3.

The incidence rate of ANC1 uptake decreased by 0.7% (IRR 0.993, 95%CI 0.990 to 0 .997; P<0.0001) (N =15,150), and ANC4 uptake decreased by 1.8% (IRR 0.982, 95%CI 0.976 to 0.987; P<0.001) (N=5850) in the first six months of the pandemic.

7.Conclusion

Authors should be selective to generalize the whole finding what they have gotten from the finding. It is not clear that why the authors select only three views (ANC access, uptake and provision) for conclusion?

Author response

We acknowledge your concern, and ANC access, uptake, and provision were identified themes in the qualitative findings and pertinent findings in this study that add new insight to the impact of COVID-19 on ANC provision in this study. Our quantitative and qualitative findings indicated that ANC access, uptake and provision were affected during the pandemic. These three issues (ANC access, uptake, and provision) have been identified as a conduit that affects women attending hospitals for ANC and are essential for policymakers to develop strategies for increasing and sustaining ANC access, uptake, and provision during any future pandemic. Therefore, understanding ANC access, uptake, and provision is crucial for increasing the coverage and quality of ANC, especially in low and low-middle-income countries.

8.Keywords

The author should select MESH terms for key word selection

Author response

Thank you for your comment, the revision has been made in line 65, page 3.

Keywords: ANC access, uptake, provision, COVID-19, Ethiopia

9. The first sentence needs citation–page 2, line49-50

Author response

Thank you for your comment, the revision has been made in line 68, page 3.

1. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109:102433.

10. Please avoid the use of reference repeatedly. E.g. reference 1, 3, etc. repeated more than two times.

Author response

Thank you for your comment, the revision has been made in lines 69-78, page 3.

11. Page 3 line 69, insert citation of reference (9) at the end of sentence.

Author response

Thank you for your comment, the revision has been made in line 88, page 4.

In 2016, the WHO recommended a minimum of eight ANC contacts for all pregnant women (11).

Methods

12. Please Rewrite as <Methods and Materials>

Author response

Thank you for your comment, the revision has been made in line 109, page 4.

Methods and materials

13. Setting

All information presented here are mentioned in the methods section. So please try to merge it or delete one them since in scientific paper writing form no need of redundancy. What are your study settings/institutions? It is not clearly stated, and try to focus on your study area and selected settings.

Author response

Thank you for your comment, the revision has been made by merging, deleting, and focusing on our study setting. Described in detail in lines 111-122, page 5.

This study is part of a larger mixed-methods study on the impact of COVID-19 on maternal and perinatal care at public hospitals in the Sidama region of southern Ethiopia. This mixed-methods study was carried out between 14 February 2022 and 10 May 2022 at fifteen public hospitals in the Sidama region. The Sidama region is the 10th newly established region in Ethiopia. The region is currently divided into five city administrations and 31 administrative divisions, known as 'Woredas'. In 2019/2020, the region's total population was 3,983,969, with 1,974,455 males and 2,009,514 females. This region has 928,265 women of reproductive age (15-49), 137,845 of whom gave birth in 2019/2020. This region comprises 14 primary hospitals, three general hospitals, one comprehensive specialised teaching hospital, 123 public health centres, 526 health posts and greater than 108 private clinics. Comprehensive emergency obstetric care (CEmOC) was available in 15 public hospitals in the Sidama region in 2020.

14. Setting

Please rewrite the whole paragraph of this section. No need of writing unnecessary information in study setting like the first sentence you wrote about study design <We implemented an interrupted time series (ITS) study design to estimate the average 126 changes in ANC provision during the first six months of the COVID-19 pandemic (March to 127 August 2020) at fifteen public hospitals in the Sidama region. ITS is a study design that 128 evaluates the impact of population-level interventions, including policy changes, infection 129 prevention programmes, and any pandemics like COVID-19 that have been implemented at a 130 clearly defined time (33)>.

Author response

Thank you for your comment, the revision has been made in lines 132-138, pages 5 & 6.

Data was collected from all fifteen public hospitals that provided CEmOC in the Sidama region. In this study, we included all pregnant women who uptake before COVID-19 (12 months from March 2019 to February 2020) and during COVID-19 (six months from March 2020 to August 2020) at public hospitals in the Sidama region. The first author and research assistants, who have MSc in clinical midwifery, extracted data from fifteen public hospitals HMIS in the Sidama region.

15. Sample size not determined. Why?

Author response

Thank you for your comment, the revision has been made in lines 132-136, page 5.

This study included all pregnant women who uptake ANC before COVID-19 (12 months from March 2019 to February 2020) and during COVID-19 (six months from March 2020 to August 2020) at fifteen public hospitals in the Sidama region (the total number of women attending 15 hospitals for ANC from March 2019 to August 2020 was (N=21,000)).

16. Data processing and analysis

It lacks focus. It should describe about data entry and analysis, but not data collection methods, data collection procedures etc.

Author response

Thank you for your comment, the revision has been made in lines 144-146, page 6.

After screening the data, any questions related to data clarity were resolved by revisiting the hospitals and regional health HMIS offices. Data were imported from Microsoft Excel into STATA V.17 for analysis.

Qualitative methods

17. Please omit redundancy. Your method part is not clear as a whole. You have three section methods in this document (methods, quantitative methods, and Qualitative methods). You should have one comprehensive methods or a max of two sections of methods.

Author response

Thank you for your comment, the revision has been made in line 109, page 4 (Methods and materials), line 131, page 5 (data collection methods for quantitative strands), line 143, page 6 (data processing and analysis for quantitative strands), in line 172, page 7 (study approach for qualitative strands), in line 183, page 7,(study participant recruitment and sampling technique for qualitative strands), in line 193, page 7,(data collection tools and procedure for qualitative strands) and in line 207 page 8 (data processing and analysis for qualitative strands).

18. Study participant recruitment and sampling technique

Author response

Thank you for your comment, the study participant recruitment and sample technique are described in lines 184-192, page 7.

We explained the purpose of the study to the hospital medical director, chief executive director and maternity care head to get permission to conduct the research. Two research assistants, who have MSc in clinical midwifery, explained in detail the purpose of the study for maternity care providers to volunteer to participate in the interview. We used a purposive sampling technique to recruit staff who provided maternity care before and during the pandemic. Participants gave written informed consent prior to being interviewed. We aimed to recruit approximately 20 participants (10 midwives and 10 obstetricians). Data were saturated at 24 interviews. We conducted another four interviews to confirm that data were saturated prior to ceasing qualitative data collection.

19. Who is your research assistant? Please clearly mentioned them

Author response

Thank you for your comment, the revision has been made in line 137, page 5.

Research assistan

Attachment

Submitted filename: Authors response to reviewers.docx

pone.0301994.s004.docx (63.7KB, docx)

Decision Letter 1

Ephraim Kumi Senkyire

10 Aug 2023

PONE-D-23-07658R1

Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods study

PLOS ONE

Dear Dr. Kassa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected.

I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision.

Kind regards,

Ephraim Kumi Senkyire

Academic Editor

PLOS ONE

Additional Editor Comments:

Thank you for considering PLOSONE. Base on reviewer 2 detailed comments to refined your manuscript to meet the quality of mix-study, after careful cross-check with your response, most of the comment were not taken into consideration. e.g you claimed the study is a mixed method however, you failed to report or discuss the quantitative aspect of the study. this is one of the several vital comment you refused to address hence your manuscript can not be accepted in this journal.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

- - - - -

For journal use only: PONEDEC3

PLoS One. 2024 Apr 18;19(4):e0301994. doi: 10.1371/journal.pone.0301994.r004

Author response to Decision Letter 1


21 Oct 2023

Reviewer 2 comments Authors rebuttal

1. The study is already over-researched, even a systematic review of meta-analysis has been done in Ethiopia entitled with <Impact of COVID-19 pandemic on utilisation of essential maternal healthcare services in Ethiopia: A systematic review and meta-analysis> or Link

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281260

So, what you added to your finding?

We appreciate the reviewer's concern regarding the over-researched issue related to our study. To the best of our search and knowledge, no study is exploring the impact of COVID-19 on ANC access, uptake, and provision in a rigorous method. Included studies in this systematic review and meta-analysis (the link you provided) and other studies used the impact of COVID-19 on ANC utilisation; however, they are quite different. The detailed difference between our study and other studies conducted in Ethiopia is as follows:

1. Most of the studies do not show ANC access, uptake, and provision before and during the pandemic. However, they showed ANC uptake during the pandemic without comparing it to before the pandemic, and they did not explore the impact of COVID-19 on ANC access, uptake, and provision.

2. There are also methodological differences; the current study differs from previously published studies on the analysis model employed in the quantitative study and integration of quantitative and qualitative findings. Hence, previously published studies employed a binary logistic regression model, Paired t-test and non-parametric (Wilcoxon signed-rank) tests to estimate the trends of ANC uptake before and during the pandemic. However, the current study used interrupted time series analysis to estimate the trend of ANC uptake before and during the pandemic based on the recommendations from three biostatisticians. As described in the methods section of this paper, the rationale for using the interrupted time series analysis is found in lines 140-145 of page 5. Interrupted time series analysis is a robust statistical analysis method that recommends evaluating the impact of population-level interventions, including policy changes, infection prevention programmes, and pandemics like COVID-19 that have been experienced at a clearly defined time.

3. As described in lines 152-155, page 5, we used the Poisson regression model because the outcome of interest is count data. Furthermore, in the current study, we controlled seasonal and other incidents' effects during the analysis.

4. We used Braun and Clarke’s thematic analysis approach using NVivo 12 plus, which followed six phases to identify themes in our qualitative study. This has not been conducted in previously published articles from Ethiopia.

5. Our qualitative findings explored the impact of COVID-19 on ANC access, uptake, and provision in a rigorous method, while previous studies did not rigorously explore the impact of COVID-19 on ANC access, uptake, and provision independently.

6. We integrated the quantitative and qualitative findings in a joint display analysis based on the recommendations from John W. Creswell’s book (2014) and Fetters MD (2019), which showed three types of integration for concurrent mixed methods study data transformation, joint display technique and side-by-side (weaving) in the discussion section. In this study, we used the joint display approach, presented in Table 3; however, previous studies do not indicate which integration approach was used in concurrent mixed methods study.

7. In summary, the above justifications clearly show the difference between our current study from previously published works in the same area in Ethiopia. This study contributes to the body of evidence about critical issues and how stakeholders can maintain and enhance ANC access, uptake, and provision for future health systems in crisis related to the epidemic, pandemic, and any natural and man-made disaster. Additionally, this study adds to the body of knowledge and aims to contribute vital evidence to inform the planning and management of future population-level disasters (including epidemic/pandemic situations).

2. The title should be rewrite in SMART form meaning that mainly it should clear where (specifically for local reader better to add < Sidam Region, Ethiopia> and when the study done. Thank you for your comment; the revision has been made in line 1, page 1.

Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed method study

Abstract

3. Methods section

What is the exact data collection period? The revision has been made in lines 30-31, page 2.

A concurrent mixed methods study was applied between 14 February 2022 and 10 May 2022 at fifteen public hospitals in the Sidama region.

4. What is your sample size? It is not clear to the reader. The following revision has been made in lines 25-28, pages 1 and 2:

The total numbers in the ANC1 cohort (at least one ANC contact) and ANC4 cohort (at least four ANC contacts) were 15,150 and 5,850, respectively, forming a combined final dataset of 21,000 women.

As we used data from all the women who accessed ANC from March 2019 to August 2020, there was no need for a sample size calculation.

5. The author collect data before covid 19 (March 2019 to February 2020), so how to relate the study with covid 19? Our objective was to estimate the monthly attendance of women for ANC at public hospitals by comparing data before and data during the pandemic. This allowed us to assess monthly trends of ANC attendance, and to control for seasonal and other influencing effects. We extracted data from HMIS at 15 public hospitals for the monthly report before COVID-19 (March 2019 to February 2020) (twelve months of data) and during COVID-19 from March to August 2020 (six months of data) to estimate monthly trends of ANC uptake before and during the pandemic, as described in lines 38-35, page 2.

We used an interrupted time series model to estimate trends of monthly ANC uptake in the two periods (before and during COVID-19). Routinely collected monthly data were derived from the hospitals’ health management information system (HMIS) and imported into Stata version 17 for analysis.

6.Result

No information mentioned about the quantitative data in your result. So please include them. The revision has been made in lines 43-44, page 2. Our findings indicate that ANC1 uptake and ANC4 uptake, respectively, decreased by 0.7% and 1.8% in the first six months of the pandemic.

7.Conclusion

Authors should be selective to generalize the whole finding what they have gotten from the finding. It is not clear that why the authors select only three views (ANC access, uptake and provision) for conclusion? We acknowledge the reviewer’s concern, and ANC access, uptake, and provision were identified themes in the qualitative findings and pertinent findings in this study that add new insight to the impact of COVID-19 on ANC provision in this study. Our quantitative and qualitative findings indicated that ANC access, uptake and provision were affected during the pandemic. These three issues (ANC access, uptake, and provision) have been identified as a conduit that affects women attending hospitals for ANC and are essential for policymakers to develop strategies for increasing and sustaining ANC access, uptake, and provision during any future pandemic. Therefore, understanding ANC access, uptake, and provision is crucial for increasing the coverage and quality of ANC, especially in low and low-middle-income countries.

8.Keywords

The author should select MESH terms for key word selection The revision has been made in line 58, page 3.

Keywords: ANC access, uptake, provision, COVID-19, Ethiopia

9. The first sentence needs citation–page 2, line49-50 The revision has been made in line 61, page 3.

1. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109:102433.

10. Please avoid the use of reference repeatedly. E.g. reference 1, 3, etc. repeated more than two times. The revision has been made in lines 64-71, page 3.

11. Page 3 line 69, insert citation of reference (9) at the end of sentence. The revision has been made in line 81, page 3.

In 2016, the WHO recommended a minimum of eight ANC contacts for all pregnant women.

Methods

12. Please Rewrite as <Methods and Materials> We appreciate the reviewer's concerns; we did not use any materials. Therefore, we put it as “methods.”

13. Setting

All information presented here are mentioned in the methods section. So please try to merge it or delete one them since in scientific paper writing form no need of redundancy. What are your study settings/institutions? It is not clearly stated, and try to focus on your study area and selected settings. The revision has been made by merging, deleting, and focusing on our study setting. Described in detail in lines 103-114, page 4.

The revision has been made as follows:

This study is part of a larger mixed-methods investigation of the impact of COVID-19 on maternal and perinatal care at 15 public hospitals in the Sidama region of southern Ethiopia, carried out between 14 February and 10 May 2022. Sidama is the 10th newly established region in Ethiopia. The region is currently divided into 5 city administrations and 31 administrative divisions, known as ‘Woredas’. In 2019/2020, the region’s total population was 3,983,969, with 1,974,455 males and 2,009,514 females. Sidama has 928,265 women of reproductive age (15–49), 137,845 of whom gave birth in 2019/2020. Regarding healthcare provision, the region has 14 primary hospitals, 3 general hospitals, 1 comprehensive specialised teaching hospital, 123 public health centres, 526 health posts, and over 108 private clinics. Comprehensive emergency obstetric care was available in 15 public hospitals in Sidama during 2020.

14. Setting

Please rewrite the whole paragraph of this section. No need of writing unnecessary information in study setting like the first sentence you wrote about study design <We implemented an interrupted time series (ITS) study design to estimate the average 126 changes in ANC provision during the first six months of the COVID-19 pandemic (March to 127 August 2020) at fifteen public hospitals in the Sidama region. ITS is a study design that 128 evaluates the impact of population-level interventions, including policy changes, infection 129 prevention programmes, and any pandemics like COVID-19 that have been implemented at a 130 clearly defined time (33)>. The revision has been made as follows:

Data were collected from all 15 public hospitals providing comprehensive emergency obstetric care in Sidama at the time of the study. The sample included all pregnant women who attended ANC in the 12 months before the COVID-19 pandemic (March 2019 to February 2020) and during the six months of the pandemic (March to August 2020), totalling 21,000.

15. Sample size not determined. Why? The following revision has been made in lines 125-131, page 5:

Data were collected from all 15 public hospitals providing comprehensive emergency obstetric care in Sidama at the time of the study. The sample included all pregnant women who attended ANC in the 12 months before the COVID-19 pandemic (March 2019 to February 2020) and during the six months of the pandemic (March to August 2020), totalling 21,000 women. As we used data from all the women who attended ANC from March 2019 to August 2020, there was no need for a sample size calculation.

16. Data processing and analysis

It lacks focus. It should describe about data entry and analysis, but not data collection methods, data collection procedures etc. The revision has been made in lines 140-144, page 5.

After screening the data, any questions regarding data clarity were resolved by revisiting the hospitals and regional HMIS offices. Data were imported from Microsoft Excel into Stata version 17 for analysis. We performed an interrupted time series analysis (ITSA) to estimate trends in the uptake of ANC across two periods: before COVID-19 (March 2019 to February 2020) and during COVID-19 (March to August 2020).

Qualitative methods

17. Please omit redundancy. Your method part is not clear as a whole. You have three section methods in this document (methods, quantitative methods, and Qualitative methods). You should have one comprehensive methods or a max of two sections of methods. The revision has been made, methods in one section in line 101, page 4

Methods

18. Study participant recruitment and sampling technique The study participant recruitment and sample technique are described in lines 188-198, page 7.

Within each chosen hospital, we explained the study’s purpose to the hospital medical director, chief executive director, and maternity care head, seeking their permission to conduct the research. Subsequently, two research assistants (both with an MSc in clinical midwifery) explained the study’s purpose in detail to maternity care providers who volunteered to be interviewed. We used purposive sampling to recruit staff who provided maternity care both before and during the pandemic. All participants provided written informed consent prior to being interviewed. We aimed to recruit approximately 20 participants (10 midwives and 10 obstetricians). Data reached saturation at 24 interviews. We conducted another four interviews to confirm that data were saturated before ending qualitative data collection.

19. Who is your research assistant? Please clearly mentioned them Research assistants who have MSc in clinical midwifery were not included as authors in this manuscript. As they were data collectors, they did not meet the criteria for co-authorship of the paper. The responsibility of research assistants was to facilitate the data collection process, for example, in the study participants’ selection process and facilitate the interviews.

“We” is used in this manuscript for those who are included as authors.

20. What are your study participants? Patient or healthcare provider As stated in lines 176-177 on pages 6 & 7, the study participants are maternity care providers (midwives, obstetrics and gynaecology residents, integrated emergency surgical officers and obstetricians).

21. Why the authors used a purposive sampling technique? Is that good to use non probable sampling methods to write scientific papers important for scientific evidence? In my view it is not acceptable. Purposive sampling was used for the qualitative component of this mixed methods study, as per usual practice. We prepared open-ended questions that addressed our objectives, and it was piloted outside of the study area. It is common in qualitative research to use a purposive sampling technique as it is necessary to be sure the participants have the appropriate experience to contribute to the data. The qualitative study focuses on the depth of individual views and experiences related to our study objectives; therefore, the participants need to have worked in the relevant hospital settings before and during the pandemic. The last author on this paper is a senior academic with a PhD and more than a decade’s experience in qualitative methodologies and methods.

22. Please insert this sentence in <Participants provided written informed consent prior to being interviewed> in Ethical approval and consent section. The revision has been made in lines 234, page 8.

Participants provided written informed consent prior to being interviewed.

23. What about Study participant recruitment and sampling technique of quantitative methods?? The following revision has been made in lines 125-131, page 5.

Data were collected from all 15 public hospitals providing comprehensive emergency obstetric care in the Sidama region at the time of the study. The sample included all pregnant women who attended ANC in the 12 months before the COVID-19 pandemic (March 2019 to February 2020) and during the six months of the pandemic (March to August 2020), totalling 21,000 women.

We collected data from the medical records of all women who attended ANC from March 2019 to August 2020, therefore, there was no need for recruitment of individuals or for a sample size calculation. In addition, interrupted time serie

Attachment

Submitted filename: V 5 Authors response to reviewers_V5.docx

pone.0301994.s005.docx (57.6KB, docx)

Decision Letter 2

Fekede Asefa Kumsa

24 Jan 2024

PONE-D-23-07658R2Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods studyPLOS ONE

Dear Dr. Kassa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by 27 Feb 2024. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Fekede Asefa Kumsa, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Additional Editor Comments (if provided):

One of the significant issues in this manuscript is a lack of focus and idea fragmentation. In the findings section, similar ideas and quotes appear in multiple places. For instance, the community's perception of health facilities as the epicenter of COVID-19 infection is displayed at various points under different themes or sub-themes. The same issue arises with transportation-related issues. There is a misalignment between some themes/subthemes and the provided descriptions. For example, in the sub-theme 'Community discrimination against women attending hospital,' the description addresses both community discrimination against women and care providers while the subtheme is about women. It is crucial for the theme/subtheme and the description to align cohesively. The finding section benefit from proper resynthesis. Additionally, the manuscript focuses on the impact of COVID-19 on antenatal care provision. However, unrelated issues regarding vaccine hesitancy are introduced in the findings section without proper context.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: (No Response)

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: No

Reviewer #4: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: I Don't Know

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: No

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: No

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: Reviewer comments

Manuscript Number: PONE-D-23-07658R2

Full Title: Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods study

Generally, the manuscript need thorough English language edition. The punctuation and grammar need correction to facilitate easy understanding for readers.

Title: Is effect or impact appropriate term to indicate results of covid-19 during mentioned times (six months, March to August 2020). This times as authors may remember was when there were complete to partial closure of services (the government declared a five-month national state of emergency starting April 8th, 2020), it was not time when services put in to place or cease of closure.

Abstract

Background: what was study gaps that authors want to uncover?

Method: Did authors calculate minimum sample size? How authors selected these facilities and participants? How authors maintained data quality? How quantitative data were reported?

Result: line 37 and 38, the sentence is not clear. Was the effect of covid-19 significant? Line 41 subtheme ‘COVID-19 vaccine hesitancy’ was identified by authors. Was there a vaccine during specified time? I recommend these subthemes categorized under their themes, so that effect of covid-19 seen boldly.

Conclusion and recommendation: is qualitative or quantitative result support this conclusion? Or both? Authors did not indicate adequate finding that support their conclusion in result part of the abstract. Are your recommendation supported by your evidence and updated? What is the study implication?

Introduction

Authors did not indicate study gaps, why this study is needed. What is the significance of this study? Why qualitative study needed? What is the objective of qualitative study?

Method

Line 100 what specific design was used for quantitative study? How about qualitative study? These two terms are broad terms to describe design, authors need to explain specific design they employed for both type of study.

Line 107, rewrite the subtitle. ‘Data collection method for quantitative data’ The content should also clearly indicate the tool used, who collected and how you collected the data.

Collection tools and procedure for qualitative data

How authors interviewed those who have difficulties in speaking official language?

Authors failed to explain how they assured quality of data for both quantitative and qualitative methods.

Result

How many was the response rate? Was there any missing data? How it was managed?

Change the following subtitle ‘Qualitative results’ to appropriate subtopic. Check its content and choose.

The authors are not expected to write ‘quote’ for each paragraphs. Too many quote indicate poor analysis of the data.

Discussion

Authors should focus on the major findings. This discussion is not easy to understand and focused.

Conclusion

Is the disruption is still there? Authors should cautiously conclude and recommend based on their findings. It may contribute to knowledge of what happened during covid-19. Otherwise, I don’t think this conditions are still there in Sidama.

Reviewer #4: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-23-07658_R2_feedback.docx

pone.0301994.s006.docx (15.3KB, docx)
PLoS One. 2024 Apr 18;19(4):e0301994. doi: 10.1371/journal.pone.0301994.r006

Author response to Decision Letter 2


19 Feb 2024

Dear Editor and reviewers,

Thank you for taking the time to review our manuscript and for your constructive comments and suggestions, which are vital to improving the quality of the manuscript. We addressed your comments point by point, provided clarifications, and incorporated your suggestion into the manuscript as follows:

Editor comments

1. In the findings section, similar ideas and quotes appear in multiple places. For instance, the community's perception of health facilities as the epicenter of COVID-19 infection is displayed at various points under different themes or sub-themes.

Authors response

Thank you for your comment; the following revision has been made in lines 335 and 337, page 15. The term ‘Epicentre of COVID-19 infection’ only appears in the ‘Fear of contracting COVID-19’ subtheme.

2. The same issue arises with transportation-related issues.

Authors response

Thank you for your comment; the following revision has been made in lines 271 and 275, page 13. The term ‘transport’ only appears in the ‘Shortage of resources’ subtheme.

3. There is a misalignment between some themes/subthemes and the provided descriptions. For example, in the sub-theme 'Community discrimination against women attending hospital,' the description addresses both community discrimination against women and care providers while the subtheme is about women.

Authors response

The following revision has been made in line 288, page 13.

Community discrimination against those attending the hospital

4. The finding section benefit from proper resynthesis. Additionally, the manuscript focuses on the impact of COVID-19 on antenatal care provision. However, unrelated issues regarding vaccine hesitancy are introduced in the findings section without proper context.

Authors response

Dear editor, we appreciate your concern regarding the relation between ANC and vaccine hesitancy.

Vaccine hesitancy could affect ANC provision, as stated in Table 3.

The qualitative findings demonstrate that COVID-19 vaccine hesitancy impacted ANC provision. The vaccine hesitancy amongst maternity care providers could have increased the reluctance of pregnant women to be vaccinated, since the providers may not have persuaded them of the vaccine’s benefits during pregnancy. Furthermore, vaccine-hesitant maternity care providers’ fear of contracting the virus when providing ANC could have further reduced ANC provision.

5. The finding section benefit from proper resynthesis.

Authors response

Thank you for your comment; the qualitative finding synthesis was reviewed iteratively as per the approach of Clarke and Braun in thematic analysis, and modifications have been made across the synthesis of the findings.

Reviewer 3 comments

1. Generally, the manuscript need thorough English language edition. The punctuation and grammar need correction to facilitate easy understanding for readers.

Authors response

Thank you for your comment; the manuscript has been reviewed in detail by two senior authors, both native English speakers and an English expert person. Grammarly Premium was used to check the manuscript's spelling, grammar, and punctuation. Additionally, the manuscript was edited and proofread by Elsevier language editing services.

2. Is effect or impact appropriate term to indicate results of covid-19 during mentioned times (six months, March to August 2020).

Authors response

We appreciate your concern; we believe ‘impact’ is an appropriate term for this study. Impact is often used to describe the immediate influence of COVID-19 on ANC.

3. what was study gaps that authors want to uncover?

Authors response

The following revision has been made in lines 18 and 19, page 1:

There is a paucity of studies on the impact of COVID-19 on antenatal care access, uptake, and provision in Ethiopia.

4. Did authors calculate minimum sample size?

Authors response

As stated in lines 131-135, page 5, data were collected from all 15 public hospitals providing comprehensive emergency obstetric care in the Sidama region at the time of the study. The sample included all pregnant women who attended ANC in the 18 months before the COVID-19 pandemic (March 2019 to February 2020) and during the six months of the pandemic (March to August 2020), totalling 21,000 women. As we used data from all the women who attended ANC from March 2019 to August 2020, there was no need for a sample size calculation.

Furthermore, this study is part of a broader mixed methods study, and a minimum sample size was calculated. In fact, it is mandatory to calculate the sample size, so the single population proportion formula was used. The health coverage in the Sidama region 2019/2020 was 77.2%. The level of significance was 5 %(a=0.05), the margin of error was 3 % (d=0.03), and the non-responsive rate was 10%; the final sample was 826.

5. How authors selected these facilities?

Authors response

All 15 public hospitals that provided comprehensive emergency obstetrics in the Sidama region were included in the quantitative study. However, as stated in lines 172 -180, pages 6 and 7, four hospitals were selected for the qualitative study. These four public hospitals (including two primary hospitals, one general hospital and one specialised hospital) were chosen for the qualitative study based on the caseload maternity care services provided and the order in which COVID-19 cases were initially reported in the Sidama region. Three different types of hospitals were selected: primary, general, and one specialised hospital that served as a referral centre for the Sidama region and the surrounding population in the Oromia region. This selection allowed for a nuanced understanding of the impact of the pandemic on various tiers of hospitals and their preparedness, response efficiency and the challenges they faced.

6. How authors selected these participants?

Authors response

The quantitative data extraction was stated in lines 132-135, page 5:

Data were collected from all 15 public hospitals providing comprehensive emergency obstetric care in the Sidama region at the time of the study. The sample included all pregnant women who attended ANC in the 12 months before the COVID-19 pandemic (March 2019 to February 2020) and during the six months of the pandemic (March to August 2020), totalling 21,000.

For qualitative study, the study participants' selection was described in lines 182 -190, page 7.

Within each chosen hospital, we explained the study’s purpose to the hospital medical director, chief executive director, and maternity care head, seeking their permission to conduct the research. Subsequently, two research assistants (both with an MSc in clinical midwifery) explained the study’s purpose in detail to maternity care providers who volunteered to be interviewed. We used purposive sampling to recruit staff who provided maternity care both before and during the pandemic. All participants provided written informed consent prior to being interviewed. We aimed to recruit approximately 20 participants (10 midwives and 10 obstetricians). Data reached saturation at 24 interviews. We conducted another four interviews to confirm that data were saturated before ending qualitative data collection.

7. How authors maintained data quality?

Authors response

Thank you for your comment; the quantitative data quality was maintained by revisiting the hospitals and HMIS offices to address any missing data in the provided Excel spreadsheet, as stated in lines 142 and 143, page 5. Data cleaning and preprocessing were done to check missing data. In addition, based on the study objective, the authors selected robust methods of analysis, which is an interrupted time series analysis through a poison regression model.

The interview guide was approved by the Ethics Committees at UTS HREC and IRB Hawassa University.

For the qualitative study, the data quality was maintained by preparing a study guide and conducting a pilot study, as stated in line 197, page 7:

The audio recordings were transcribed immediately and listened to iteratively. Simultaneously, bilingual researchers transcribed and translated transcripts into English to check consistency. The transcriptions were imported into NVivo software (QSR International, version 12 Plus) to manage the overall data analysis, as stated in lines 206-209, page 8. All authors reviewed the themes and subthemes in the thematic analysis phases (from coding to writing a report) and approved the final themes, as stated in lines 213 -215, page 8.

8. How quantitative data were reported?

Authors response

The quantitative data were reported based on assumptions of the model (Poisson regression) using a P value less than 0.05 (p<0.05), which is considered statistically significant, and using a 95% confidence interval. The incidence rate ratio (IRR) of ANC1 and ANC4 is reported in the figure, table, and texts, which are stated in lines 150-157, page 6. In addition, we based our reporting on journal submission guidelines.

The mean monthly incidence rate ratio (IRR) of ANC uptake was calculated with a 95% confidence interval (CI) using a Poisson regression model (34, 35) with pre-COVID-19 data as the reference. A Poisson regression model was suitable because the monthly reports of ANC provision comprised count data (non-negative integer values). In ITSA, a Poisson regression model (36) performs better than an autoregressive integrated moving average (ARIMA) model, which is more conventionally used for real-valued time series data. Differences are considered statistically significant at a p-value of less than 0.05 (p < 0.05).

9. Result: line 37 and 38, the sentence is not clear. Was the effect of covid-19 significant?

Authors response

Thank you for your comment: the revision has been made in lines 40 and 41, page 2:

Our findings indicate a significant monthly decrease of 0.7% in ANC1 and 1.8% in ANC4 during the first six months of the pandemic.

10. Line 41 subtheme ‘COVID-19 vaccine hesitancy’ was identified by authors. Was there a vaccine during specified time? I recommend these subthemes categorized under their themes, so that effect of covid-19 seen boldly.

Authors response

We understand your concern: the data were collected between 14 February and 10 May 2022. During the data collection, COVID-19 vaccinations were available. Some study participants reported that they did not get vaccinations, for a variety of reasons. These factors could potentially have disrupted the provision of ANC. Further details are provided in Table 3.

The qualitative findings demonstrate that COVID-19 vaccine hesitancy impacted ANC provision. Such hesitancy in maternity care providers could have increased the reluctance of pregnant women to be vaccinated, since the providers would not attempt to persuade them of the vaccine’s benefits during pregnancy. Furthermore, vaccine-hesitant maternity care providers’ fear of contracting the virus when providing ANC could have further reduced ANC provision.

11. Conclusion and recommendation: is qualitative or quantitative result support this conclusion? Or both? Authors did not indicate adequate finding that support their conclusion in result part of the abstract. Are your recommendation supported by your evidence and updated? What is the study implication?

Authors response

Thank you for your comment; the following revision has been made in lines 51-57, pages 2 and 3, and the conclusion and recommendation are derived from our concurrent mixed methods findings.

A lack of medical supplies, discrimination against those attending the hospital, and the absence of ANC guidelines for care provision led to disrupted access, uptake, and provision of ANC during COVID-19. To mitigate disrupted ANC access, uptake and provision, ANC clinics should be equipped with medical supplies. It is crucial to maintain rapport between the community and maternity care providers and provide training for maternity care providers regarding the adapted/adopted guidelines during COVID-19 at the hospital grassroots level for use in the current and future pandemics.

12. Authors did not indicate study gaps, why this study is needed. What is the significance of this study? Authors response

Thank you for your comment; the revision has been made in lines 97-109, page 4.

In the early stage of the COVID-19 pandemic, Ethiopian government and NGOs shifted their focus towards containing the spread of the virus by implementing a range of measures. These measures included declaring a state of emergency, reducing the passenger capacity in public transport by half, imposing a lockdown and encouraging people to stay at home (27). Consequently, the lockdown measures resulted in job losses for many women (28). These factors posed significant challenges to women’s ability to meet their basic needs (28). As a result, the provision of ANC has been and continues to be, impacted by the direct and indirect consequences of COVID-19 (29). However, the existing studies in Ethiopia on the impact of the COVID-19 pandemic have not rigorously explored its impact on maternity care services, specifically ANC access, uptake, and provision. The paucity of studies on the impact of COVID-19 on ANC access, uptake and provision in Ethiopia made it essential to conduct this study to estimate and explore the impact of COVID-19 on the country’s ANC access, uptake, and provision.

In addition, most of the studies show in their titles that they have conducted a mixed methods study, but in many cases, it was simply qualitative and quantitative studies. When studies lack integration and do not tell us which techniques of integration were used and applied in the method, result, or discussion section, this is not truly mixed methods. However, in this study, we integrated the quantitative and qualitative findings in a joint display technique based on the recommendations from John W. Creswell’s book (2014) and Fetters MD (2019), which showed three types of integration for concurrent mixed methods- study data transformation, joint display technique and side-by-side (weaving) in the discussion section. In this study, we used the joint display approach, presented in Table 3; however, previous studies do not indicate which integration approach was used.

13. Why qualitative study needed? What is the objective of qualitative study?

Authors response

Dear reviewer, we appreciate your concern regarding the study methods. We applied a concurrent mixed methods study to estimate and explore the impact of COVID-19 on ANC at public hospitals. The quantitative findings estimate the trends of ANC in the first 12 months before COVID-19 and in the first six months of the pandemic. Simultaneously, the qualitative findings explore maternity care providers' experiences and perceptions of ANC provision before and during the pandemic. The objective of this mixed methods study was to explore whether the qualitative findings confirmed or disconfirmed the quantitative findings.

14. Line 100 what specific design was used for quantitative study?

Authors response

Thank you for your comment; the revision has been made in lines 124, page 5

An interrupted time series design was applied for the quantitative component of the study.

15. How about a qualitative study?

Authors response

As stated in line 169, page 6, we adopted an exploratory design to investigate maternity care providers’ views and experiences of the impact of COVID-19 on ANC provision in the Sidama region.

16. These two terms are broad terms to describe design, authors need to explain specific design they employed for both type of study.

Authors response

As stated in line 122, page 5, in this study we used a concurrent mixed-methods design.

17. Line 107, rewrite the subtitle. ‘Data collection method for quantitative data’ The content should also clearly indicate the tool used, who collected and how you collected the data.

Authors response

Thank you for your comment; the revision has been made in line 131, page 5:

Data collection methods for quantitative data

This study is part of a broader mixed methods study, focusing on the outcome variables ANC1, ANC4, and essential medicines. These variables were extracted from the HMIS office in each hospital. The data was obtained from the HMIS office at

Attachment

Submitted filename: Zemenu Kassa V 1 authors response to reviewers PLOS ONE.docx

pone.0301994.s007.docx (62.9KB, docx)

Decision Letter 3

Fekede Asefa Kumsa

8 Mar 2024

PONE-D-23-07658R3Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods studyPLOS ONE

Dear Dr. Kassa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 22 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Fekede Asefa Kumsa, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear authors,

Thank you for addressing most of the the reviewers comments. There still some minor issues need to be addressed.

1. I would suggest the authors work on the abstract section to make it more appealing, especially the result section. The second sentence of the conclusion and recommendation section seems better fit into the result section and please move it up. Please don't introduce an abbreviation in the abstract if you are not gong to use it in this section. e.g., HMIS. Your abbreviation use is actually inconsistent throughout the document. For some, you provided multiple full text description (e.g., WHO), while for some others, you started using it without providing a full text discerption at the first use (e.g., ANC). Please make sure your abbreviations use is consistent and follows the standard.

2. In the abstract section, you stated that you collected 12 months' data before the occurrence of COVID-19, while in the method section it says 18 months data were collected. Please make sure you are consistent. In addition, please also discuss the appropriateness of comparing 12 or 18 months data (before COVID-19) with 6 months data (during COVID-19).

3. Please move table 2 to supplementary file.

4. Under the community discrimination against those attending the hospital sub-theme, you clearly discussed about the community discrimination against those attending the hospital. However, you gave little emphases on its link to the access to ANC. You have tried to say a few things in a second sentence of this section, but didn't substantiate it with the data from the participants. Please clearly show the link of this sub-theme to the access to ANC by substantiating it with the data.

5. Neither your discerption nor the provided quate still doesn't show the influence of COVID-19 vaccine hesitancy on ANC service utilization. You have tried to respond on the response letter, but the description should appear on the manuscript too. Please make sure that this claim is substantiated with evidence came from the participants. It shouldn't be the authors speculation.

Best regards,

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Apr 18;19(4):e0301994. doi: 10.1371/journal.pone.0301994.r008

Author response to Decision Letter 3


12 Mar 2024

Dear Editor,

Thank you for taking the time to review our manuscript and for your constructive comments and suggestions, which are vital to improving the quality of the manuscript. We addressed your comments point by point, provided clarifications, and incorporated your suggestion into the manuscript as follows:

Editor comments

1. The second sentence of the conclusion and recommendation section seems better fit into the result section and please move it up.

Authors response

Thank you for your comment; the following revision has been made in lines 40-44, page 2, as follows:

A lack of medical supplies, fear of contracting COVID-19, inadequate personal protective equipment, discrimination against those attending the hospital, and the absence of antenatal care guidelines for care provision, COVID-19 vaccine hesitancy and long waiting times for ANC led to disrupted access, uptake, and provision of antenatal care during COVID-19.

2. Please don't introduce an abbreviation in the abstract if you are not gong to use it in this section. e.g., HMIS. Your abbreviation use is actually inconsistent throughout the document. For some, you provided multiple full text description (e.g., WHO), while for some others, you started using it without providing a full text discerption at the first use (e.g., ANC). Please make sure your abbreviations use is consistent and follows the standard.

Authors response

Thank you for your comment; the revision has been made. The abstract has been written without any abbreviation, adhering to the prescribed wordage.

The revision has been made in the introduction section, line 77, page 3 as follows:

antenatal care (ANC)

3. In the abstract section, you stated that you collected 12 months' data before the occurrence of COVID-19, while in the method section it says 18 months data were collected. Please make sure you are consistent. In addition, please also discuss the appropriateness of comparing 12 or 18 months data (before COVID-19) with 6 months data (during COVID-19).

Authors response

Thank you for your comment; the revision has been made in line 135, page 5.

Twelve months before the COVID-19 pandemic (March 2019 to February 2020).

In addition, we aimed to assess the ANC uptake during the same period initially (March to August 2019 before COVID-19) and March to August 2020 during COVID-19 to control seasonal effects. After consulting a biostatistician, we decided to include the period from September 2019 to February 2020, whether ANC has been affected by other incidences or not, to control other incidents effects as stated in lines 140-142, page 5. This study aims to assess any monthly changes in ANC1 and ANC4 attendance before COVID-19 (March 2019 to February 2020) and during COVID-19 (March to August 2020). The study was conducted while controlling seasonal effects and other incidents impacting ANC1 and ANC4 attendance. Therefore, this study compared monthly changes in ANC1 and ANC4 attendance before COVID-19 (March 2019 to February 2020) and during COVID-19 (March to August 2020).

4. Please move table 2 to supplementary file.

Authors response

The revision has been made by moving Table 2 to Supplementary Table 2.

5. Under the community discrimination against those attending the hospital sub-theme, you clearly discussed about the community discrimination against those attending the hospital. However, you gave little emphases on its link to the access to ANC. You have tried to say a few things in a second sentence of this section, but didn't substantiate it with the data from the participants. Please clearly show the link of this sub-theme to the access to ANC by substantiating it with the data.

Authors response

Thank you for your comment; the following revision has been made in lines 306 and 317, page 14, as follows:

resulting in limited access to ANC.

Consequently, this discrimination resulted in limited access to ANC.

6. Neither your discerption nor the provided quate still doesn't show the influence of COVID-19 vaccine hesitancy on ANC service utilization. You have tried to respond on the response letter, but the description should appear on the manuscript too. Please make sure that this claim is substantiated with evidence came from the participants. It shouldn't be the authors speculation.

Authors response

Thank you for your comment; the following revision has been made in lines 432-434, page 18, as follows:

If maternity care providers are hesitant about the COVID-19 vaccine, it may impact pregnant women's confidence in the vaccine's safety and efficacy. This could lead to lower vaccine rates and hinder ANC provision. In addition, at the beginning of the COVID-19 vaccine rollout, priority was given to frontline healthcare workers to enhance medical care, including ANC provision.

Attachment

Submitted filename: Zemenu Kassa authors response.docx

pone.0301994.s008.docx (40.6KB, docx)

Decision Letter 4

Fekede Asefa Kumsa

26 Mar 2024

Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods study

PONE-D-23-07658R4

Dear Dr. Kassa,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Fekede Asefa Kumsa, PhD

Academic Editor

PLOS ONE

Acceptance letter

Fekede Asefa Kumsa

8 Apr 2024

PONE-D-23-07658R4

PLOS ONE

Dear Dr. Kassa,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Fekede Asefa Kumsa

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Standards for Reporting Qualitative Research (SRQR).

    (DOCX)

    pone.0301994.s001.docx (27KB, docx)
    S2 Table. Sociodemographic characteristics of study participants (N = 28).

    (DOCX)

    pone.0301994.s002.docx (17.7KB, docx)
    Attachment

    Submitted filename: Comments.docx

    pone.0301994.s003.docx (15.3KB, docx)
    Attachment

    Submitted filename: Authors response to reviewers.docx

    pone.0301994.s004.docx (63.7KB, docx)
    Attachment

    Submitted filename: V 5 Authors response to reviewers_V5.docx

    pone.0301994.s005.docx (57.6KB, docx)
    Attachment

    Submitted filename: PONE-D-23-07658_R2_feedback.docx

    pone.0301994.s006.docx (15.3KB, docx)
    Attachment

    Submitted filename: Zemenu Kassa V 1 authors response to reviewers PLOS ONE.docx

    pone.0301994.s007.docx (62.9KB, docx)
    Attachment

    Submitted filename: Zemenu Kassa authors response.docx

    pone.0301994.s008.docx (40.6KB, docx)

    Data Availability Statement

    Data Availability Statement: The interview data cannot be shared publicly since it contains potentially attributable sensitive information regarding participants and their roles. Sharing such data would violate and undermine the ethical committee agreement and consent process. Researchers who meet the criteria for access to confidential data may request it from the University of Technology Sydney Human Research Ethics Committee at Research.Ethics@uts.edu.au. All other relevant data are presented within the paper.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES